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SCHEDULE AT A GLANCE 
 
 
Sunday 12th September 2010 
 
15.00-16.10  Session 1: Epidemiology and Public Health 
16.10-16.30  Break 
16.30-17.40  Session 1, continued 
17.40-18.30  Wine and Cheese Party 
18.30-19.30  Dinner 
19.30-20.40  Session 2: Viruses I 
20.40-21.00  Break 
21.00-21.50  Session 2, continued 
 
 
Monday 13th September 2010 
 
07.30-09.00  Breakfast 
09.00-10.40  Session 3: Viruses II 
10.30-10:50  Morning Coffee 
10:50-12:00  Session 3, continued   
12.00-14.00  Lunch 
14.00-15.30  Session 4: Population Genomics 
15.30-15.50  Break 
15.50-17.00  Session 4, continued  
17.00-19.30  Poster Session I 
19.30-21.00  Dinner                               
 
 
Tuesday 14th September  2010 
 
07.30-09.00  Breakfast 
09.00-10.30  Session 5: Bacteria 
10.30-10.50  Morning Coffee 
10.50-12.20  Session 5, continued 
12.20-14.00  Lunch 
14.00-15.30  Session 6: Parasites and Vectors 
15.30-15.50  Break 
15.50-17.00  Session 6, continued 
17.30-18.30  Keynote Speaker: Dominic Kwiatkowski 
18.30-19.30  Drinks Reception 
19.30   Conference Banquet 
 
General Information 
 
 
Conference Badges 
Please wear your name badge at all times to promote networking and to 
assist staff in identifying you.    
 
If you have advised us of any dietary requirements, you will find a blue dot 
on your badge. Please make yourself known to the catering team and they 
will assist you with your meal request. 
 
Scientific Session Protocol 
Photography, audio or video recording of the scientific sessions is not 
permitted. 
 
Internet Access 
Wireless internet access is available throughout the campus. Please inquire 
at reception for a Wireless Connection token. 
 
Conference Meals 
Lunch and dinner will be served in the Hall Restaurant.  Please refer to the 
conference programme in this book as times will vary based on the daily 
scientific presentations. 
 
Presentations 
If you are an invited speaker or your abstract has been selected for an oral 
presentation, please provide an electronic copy of your talk to a member of 
the AV team who will be based in the auditorium.  
 
Poster Sessions 
Posters will be displayed throughout the conference. Please post your 
materials in the Cloisters on arrival or during the afternoon break. The 
abstract page number indicates the assigned poster board number.  
 
For Wellcome Trust Conference Centre Guests 
Check in 
If you are staying on site at the Wellcome Trust you may check into your 
room from 2.00pm. If you plan to arrive late at night you can check into your 
room as the conference centre reception is open 24 hours.  Please note 
there will be no lunch or dinner facilities available outside of the conference 
timetable; however, there is a local public house (The Red Lion), serving 
both lunch and evening meals, located just 2 minutes walk from the campus 
in the village of Hinxton.    
 
Breakfast 
Your breakfast will be served in the Hall restaurant from 07.30 – 09.00 
 
 
Telephone 
If you are staying on-site and would like to use the telephone in your room, 
you will need to contact the Reception desk (Ext. 5000) to have your phone 
line activated - we will require your credit card number and expiry date to do 
so.   
 
Departures 
You must vacate your room by 10.00 on the day of your departure.  Please 
ask at reception for assistance with luggage storage in the Conference 
Centre. 
 
Taxis 
Please find a list of local taxi numbers should you require transfers 
outside of the scheduled times: 
Panther – 01223 715715 
Mid Anglia - Tel: 01223 836000 
Phil's Taxi Services - Tel: 01223 521918 
A&M Carriages (Airport Specialist) - Tel: 01223 513703 
 
Return Ground Transportation 
Complimentary return transportation to Heathrow, Stansted Airport and the 
Cambridge Train Station and City Centre have been arranged for 9.00am on 
Wednesday, 15 September. Please note: a sign up sheet will be available at 
the registration desk.  Places are limited so you are advised to book early.                
 
Messages and Miscellaneous 
All messages will be posted on the registration desk in the Conference 
Centre Foyer. 
 
A number of toiletry and stationery items are available for purchase at the 
conference centre reception.  Cards for our self-service laundry are also 
available.   
 
If you have any queries or comments, please do not hesitate to contact a 
member of staff who will be pleased to help you. 
 
  
Joint Cold Spring Harbor Laboratory/Wellcome Trust conferences 
at Hinxton are supported in part with funding courtesy of  
The Wellcome Trust. 
 
 
Additional funding for this conference was provided by Burroughs 
Wellcome Fund and New England Biolabs. 
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 vii 
PROGRAM 
 
 
SUNDAY, September 12—3:00 PM 
 
 
SESSION 1 EPIDEMIOLOGY AND PUBLIC HEALTH 
 
Chairperson: C. Arias, University of Texas Medical School, Houston,  
  USA 
P. Bejon, KEMRI Wellcome Trust Research Program,  
Kilifi, Kenya 
 
 
Use of whole genome sequencing to track the in vivo evolution of 
antimicrobial resistance in enterococci 
Cesar A. Arias. 
Presenter affiliation: University of Texas Medical School at Houston, 
Houston, Texas. 
 
 
 
 
1 
  
Diversity and evolution of Staphylococcus aureus clonal 
complexes across space and time 
Ruth Miller, Tanya Golubchik, Daniel Wilson, Helen Farr, Martin 
Llewelyn, Rory Bowden, Hanna Larner, John Paul, Nick Price, Nick 
Day, Sarah Walker, Tim Peto, Derrick Crook. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
 
 
2 
  
High-resolution genomic typing of Clostridium difficile for 
hospital-based transmission studies 
Rosalind M. Harding, Madeleine L. Cule, Tanya Golubchik, Ann S. 
Walker, Daniel Wilson, Camilla Ip, Hanna Larner, Teresa Street, Ruth 
Miller, Tim E. Peto, Kate E. Dingle, David Griffiths, Derrick W. Crook, 
Rory Bowden. 
Presenter affiliation: Oxford University, Oxford, United Kingdom. 
 
 
 
 
 
 
3 
  
Philip Bejon. 
Presenter affiliation: KEMRI Wellcome Trust Research Program,  
Kilifi, Kenya. 
 
  
Mutations underlying the recent clonal expansion of a dominant 
subclone of the Mycobacterium tuberculosis Beijing genotype 
Kristin Kremer, Anita Schuerch, Rob M. Warren, Roland J. Siezen, 
Noel H. Smith, Dick van Soolingen. 
Presenter affiliation: RIVM, Bilthoven, the Netherlands. 
 
 
 
 
4 
  
 viii 
Escherichia coli O157:H7 isolates related to the 2006 spinach-
associated outbreak exhibit distinct transcriptional profiles and 
phenotypes—The spinach bag as a selective source 
Craig T. Parker, Jennifer L. Kyle, Michelle Q. Carter, Maria T. Brandl, 
Steven Huynh, Robert E. Mandrell. 
Presenter affiliation: USDA, Agricultural Research Service, Albany, 
California. 
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SUNDAY, September 12—5:45 PM 
 
Wine and Cheese Party 
 
 
SUNDAY, September 12—7:30 PM 
 
 
SESSION 2 VIRUSES I 
 
Chairperson: R. Heyderman, Malawi-Liverpool Wellcome Trust,  
  Blantyre, Malawi 
P. Kellam, Wellcome Trust Sanger Institute, Hinxton,  
United Kingdom 
 
  
Pneumococcal pathogenesis in the context of HIV—The biology 
and the genome 
Robert S. Heyderman. 
Presenter affiliation: Malawi-Liverpool/Wellcome Trust Clinical 
Research Program, Chichiri, Malawi. 
 
 
 
 
6 
  
Volant viruses—Metaviromic study of a West African bat 
population 
Kate S. Baker, Mark Alston, Gordon Daly, Nick Bexfield, Paul Kellam, 
Jonathan L. Heeney, David T. Hayman, Andrew A. Cunningham, 
James L. Wood, Mario Caccamo, Pablo R. Murcia. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom. 
 
 
 
 
 
 
7 
  
Bioinformatics analysis over recently sequenced adenoviruses 
strains 53, 54 and intermediate 15-29-9 causing epidemic kerato-
conjunctivitis outbreaks in Japan 
Gabriel Gonzalez, Hidemi Watanabe, Kanako Koyanagi, Koki Aoki, 
Hisatoshi Kaneko. 
Presenter affiliation: Hokkaido University Graduate School of 
Information Science and Technology, Sapporo Hokkaido, Japan. 
 
 
 
 
 
 
8 
 ix 
Whole virus genome sequencing and the tracking of H1N1pdm 
introductions and virus persistence in the UK 
Gregory J. Baillie, Monica Galiano, Steve Platt, Richard Myers, 
Rachael Chiam, Astrid Gall, Anne Palser, Simon Watson, Paul-Michael 
Agapow, Anthony Underwood, Andrew Rambaut, Jonathan Green, 
Rod Daniels, Oliver G. Pybus, Maria Zambon, Paul Kellam. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom. 
 
 
 
 
 
 
 
9 
  
Sensitive population profiling and genome assembly of HIV and 
Flaviviruses using ultra-deep sequencing technologies 
Matthew R. Henn, Niall J. Lennon, Ruchi Newman, Patrick Charlebois, 
Aaron Berlin, Elizabeth Ryan, Christine Malboeuf, Monica Casali, Lisa 
Green, Sarah Young, Joshua Levin, Michael S. Diamond, Laura D. 
Kramer, Gregory D. Ebel, Eva Harris, Todd M. Allen, Bruce W. Birren. 
Presenter affiliation: Broad Institute, Cambridge, Massachusetts. 
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MONDAY, September 13—9:00 AM 
 
 
SESSION 3 VIRUSES II 
 
Chairperson: C. Simmons, Hospital for Tropical Diseases, Ho Chi Minh  
  City, Vietnam 
L. Kramer, Wadsworth Center, SUNY Albany, New York, USA 
 
  
Dengue in Vietnam—Genomics of the virus – host interaction 
Cameron Simmons. 
Presenter affiliation: Oxford University Clinical Research Unit, Ho Chi 
Minh City, Vietnam. 
 
 
 
11 
  
Occult hepatitis C virus infection—the Pakistan experience 
Muhammad M. Idrees, Amreek A. Lal, Sadia S. Butt. 
Presenter affiliation: University of the Punjab, Lahore, Pakistan. 
 
 
12 
  
Positive selection of HIV host factors and the evolution of 
lentivirus genes 
Katarzyna Bozek, Thomas Lengauer. 
Presenter affiliation: Max Planck Institute for Informatics, Saarbrücken, 
Germany. 
 
 
 
 
13 
  
 x 
Genomic analysis of mutant spectrum, fitness, and phenotype in 
RNA virus populations 
Adam S. Lauring, Ashley Acevedo, Raul Andino. 
Presenter affiliation: University of California, San Francisco, San 
Francisco, California. 
 
 
 
 
14 
  
Understanding selective pressures on arboviruses using 
experimental in vivo passage of flaviviruses 
Alex T. Ciota, Dylan J. Ehrbar, Yongqing Jia, Graham J. Willsey, Greta 
V. Jerzak, David J. Young, Laura D. Kramer. 
Presenter affiliation: Wadsworth Center, New York State Dept Health, 
Albany, New York; School of Public Health, State University of New 
York, Albany, New York. 
 
 
 
 
 
 
15 
  
Novel hantavirus detected in Yunnan Red-backed Vole, 
Eothenomys miletus 
Yun-zhi Zhang, Zheng-li Shi. 
Presenter affiliation: Chinese Academy of Sciences, Wuhan, China. 
 
 
 
16 
  
Human genetic factors that modulate HIV type 1 infection in rural 
populations in Cameroon 
Judith N. Torimiro, Nathan D. Wolfe, Donald S. Burke, Jean K. Carr, 
Michael Dean, Joseph Sodroski. 
Presenter affiliation: University of Yaounde I, Yaounde, Cameroon. 
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MONDAY, September 13—2:00 PM 
 
 
SESSION 4 POPULATION GENOMICS 
 
Chairperson: D. Conway, Medical Research Council, The Gambia 
P. Keim, Northern Arizona University, Flagstaff, USA 
 
 
David Conway. 
Presenter affiliation: Medical Research Council, The Gambia. 
 
  
A time for change—The mutation rate of Mycobacterium 
tuberculosis during latent infection 
Christopher B. Ford , Philana L. Lin, Michael R. Chase, Rupal R. Shah, 
Oleg Iartchouk, James Galagan, Marc Lipsitch, JoAnne L. Flynn, 
Sarah M. Fortune. 
Presenter affiliation: Harvard School of Public Health, Boston, 
Massachusetts. 
 
 
 
 
 
 
18 
 xi 
Hyper-recombination in Streptococcus pneumoniae—
Quantitation and potential implications 
Christophe Fraser, Nicholas J. Croucher, Stephen D. Bentley, William 
P. Hanage. 
Presenter affiliation: Imperial College London, London, United 
Kingdom. 
 
 
 
 
 
19 
  
Genome-wide analysis of microevolution in S. sonnei associated 
with increasing disease severity and drug resistance in Viet Nam 
Kathryn E. Holt, Nicholas R. Thomson, Stephen Baker. 
Presenter affiliation: University of Melbourne, Melbourne, Australia. 
 
 
 
20 
  
Contrasting clonal and non clonal bacterial pathogens’ 
population genetics: Bacillus anthracis, F. tularensis, Y. pestis 
and Burkholderia pseudomallei 
Paul S. Keim. 
Presenter affiliation: NAU/Tgen, Flagstaff, Arizona. 
 
 
 
 
21 
  
Genomic insights into the convergence of Campylobacter species 
Samuel K. Sheppard, Xavier Didelot, Aaron Darling, Michael Egholm, 
Steven D. Bentley, Julian Parkhill, Daniel Falush, Martin C. Maiden. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
22 
  
Understanding evolution through genome sequencing of 
methicillin resistant Staphylococcus aureus USA300 clinical 
isolates 
Ryan Tewhey, Christopher R. Cannavino, John A. Leake, Vikas 
Bansal, Eric Topol, Ali Torkamani, John S. Bradley, Nicholas J. 
Schork. 
Presenter affiliation: Scripps Translational Science Institute, La Jolla, 
California; University of California, San Diego, La Jolla, California. 
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MONDAY, September 13—5:00 PM 
 
 
POSTER SESSION 
 
  
Public health genomics to improve global health 
Elena Ambrosino, Angela Brand. 
Presenter affiliation: Maastricht University, Maastricht, the Netherlands. 
 
 
24 
  
 xii 
Draft genome sequence of a Trypanosoma cruzi I (TcI) strain 
Oscar Franzén, Stephen Ochaya, Ellen Sherwood, Martin Llewellyn, 
Michael Lewis, Michael A. Miles, Björn Andersson. 
Presenter affiliation: Karolinska Institutet, Stockholm, Sweden; Science 
for Life Laboratory, Solna, Sweden. 
 
 
 
 
25 
  
Seeking new genetic target of chloroquine resistance in Indian 
Plasmodium falciparum with evolutionary genomic approach 
Gauri Awasthi, Aparup Das. 
Presenter affiliation: National Institute of Malaria Research, New Delhi, 
India. 
 
 
 
 
26 
  
Genomics without genetics—The Simulium genomics project 
Charles L. Brockhouse, Soochin Cho, Guishan (Gary) Xiao, Eric J. 
Haas, John K. Colbourne. 
Presenter affiliation: Creighton University, Omaha, Nebraska. 
 
 
 
27 
  
Increased resolution of large multi-host Campylobacter jejuni and 
C. coli clonal complexes by extended multi-locus sequence 
typing 
A J. Cody, S K. Sheppard, K E. Dingle, M C. Maiden. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
 
28 
  
Comparative SOLiD™ sequencing reveals genomic patterns of 
virulence evolution in the bacterial genus Listeria 
Craig A. Cummings, Henk C. den Bakker, Vania Ferreira, Paolo Vatta, 
Renato H. Orsi, Lovorka Degoricija, Melissa Barker, Olga 
Petrauskene, Manohar R. Furtado, Martin Wiedmann. 
Presenter affiliation: Applied Biosystems, Foster City, California. 
 
 
 
 
 
29 
  
High-throughput sequencing of 16 Salmonella genomes on the 
SOLiD™ 3 Plus system 
Lovorka Degoricija, Craig Cummings, Gregory R. Govoni, Elena 
Bolchakova, Matthew L. Ranieri, Andrea Switt, Henk C. den Bakker, 
Martin Wiedmann, Manohar Furtado. 
Presenter affiliation: Life Technologies Corporation, Foster City, 
California. 
 
 
 
 
 
 
30 
  
Salmonella enterica genomics—CRISPR elements and phenotype 
evolution 
W. Florian Fricke, Mark Mammel, J. Eugene LeClerc, Jacques Ravel, 
Thomas A. Cebula. 
Presenter affiliation: Institute for Genome Sciences, Baltimore, 
Maryland. 
 
 
 
 
 
31 
  
 xiii 
Comparison of four complete genomes of Japanese Helicobacter 
pylori—Genome rearrangements and genomic islands 
Yoshikazu Furuta, Mikihiko Kawai, Koji Yahara, Takeshi Tsuru, Noriko 
Takahashi, Naofumi Handa, Kenshiro Oshima, Masahira Hattori, 
Masaru Yoshida, Takeshi Azuma, Ikuo Uchiyama, Ichizo Kobayashi. 
Presenter affiliation: Graduate School of Frontier Sciences, University 
of Tokyo, Minato-ku, Tokyo, Japan. 
 
 
 
 
 
 
32 
  
Detection of DNA methylation in Schistosoma mansoni 
Kathrin K. Geyer, Carlos M. Rodriguez Lopez, Michael J. Wilkinson, 
Karl F. Hoffmann. 
Presenter affiliation: Aberystwyth University, Aberystwyth, United 
Kingdom. 
 
 
 
 
33 
  
Whole genome sequencing reveals fine-scale genetic 
heterogeneity among S. aureus isolates from a single individual 
Tanya Golubchik, Ruth Miller, Helen Farr, Daniel Wilson, Hanna 
Larner, Rowena Fung, Heather Godwin, Derrick Crook, Rory Bowden. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
 
34 
  
Etiology of diarrhea in Bolivia 
Lucia Gonzales, Enrique Joffre, Rosario Rivera, Samanta Sanchez, 
Ann-Mari Svennerholm, Asa Sjoling, Volga Iñiguez. 
Presenter affiliation: Universtity of Gothenburg, Gothenburg, Sweden. 
 
 
 
35 
  
Population genomics of Indian Plasmodium vivax using non-
coding single nucleotide polymorphisms (SNPs) 
Bhavna Gupta, Aparup Das. 
Presenter affiliation: National Institute of Malaria Research, New Delhi, 
India. 
 
 
 
 
36 
  
Analysis of bacteria from intestinal tract of FAP patients for the 
presence of APC-like sequences 
Vladimir Holec, Sonia Ciernikova, Lenka Wachsmannova, Zuzana 
Adamcikova, Michal Mego, Viola Stevurkova, Vladimir Zajac. 
Presenter affiliation: Comenius University, Bratislava, Slovakia; 
University Children's Hospital, Banska Bystrica, Slovakia. 
 
 
 
 
 
37 
  
The role of contingency genes in the adaptation of 
Campylobacter jejuni to a novel host 
John P. Jerome, Julia A. Bell, Anne E. Plovanich-Jones, Jeff E. 
Barrick, Charles T. Brown, Linda S. Mansfield. 
Presenter affiliation: Michigan State University, East Lansing, 
Michigan. 
 
 
 
 
 
38 
  
 xiv 
Neisseria population genomics—Integrating whole genome data 
with multi locus approaches to epidemiology and population 
biology 
Keith A. Jolley, Martin C. Maiden. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
 
39 
  
Global epidemiology of enterotoxigenic Escherichia coli (ETEC) 
expressing coli surface antigen 6 (CS6) 
Matilda Nicklasson, John Klena, Rania Abdel El-Khalek, Erik Nygren, 
Anders Janzon, Firdausi Qadri, Åsa Sjöling. 
Presenter affiliation: University of Gothenburg, Göteborg, Sweden. 
 
 
 
 
40 
  
Investigating the genotype-phenotype link in invasive Salmonella 
Typhimurium 
Chinyere K. Okoro, Robert A. Kingsley, Simon R. Harris, Julian 
Parkhill, Gordon Dougan. 
Presenter affiliation: Wellcome Trust Sanger Institute, Cambridge, 
United Kingdom. 
 
 
 
 
 
41 
  
From commensal to lethal infection—Genomic analysis of E. coli 
and Shigella 
Jason W. Sahl, Julia C. Redman, Jennifer Emberger, Adam Phillippy, 
David A. Rasko. 
Presenter affiliation: Institute for Genome Sciences, Baltimore, 
Maryland. 
 
 
 
 
 
42 
  
Metagenomic analysis of viruses in bat intestinal tract, 
implication of important roles played by bats in ecosystem 
Xing-yi Ge, Yan Li, Zheng-li Shi. 
Presenter affiliation: Chinese Academy of Sciences, Wuhan, China. 
 
 
 
43 
  
Serological evidence of SARS-CoV like virus in some species of 
mammals from Hubei Province, China 
Hanzhong Wang. 
Presenter affiliation: Chinese Academy of Sciences, Wuhan, China. 
 
 
 
44 
  
Phylogenetic analysis of Escherichia coli isolates based on 
intergenic sequences reveals lifestyle adaptations but not host 
specificity 
Aaron P. White, Kristen McLeod, Ricci Schaefer, Chris D. Sibley, 
Michael G. Surette, Norm F. Neumann. 
Presenter affiliation: University of Saskatchewan, Saskatoon, Canada; 
Provincial Laboratory, Calgary, Canada; University of Calgary, Calgary, 
Canada. 
 
 
 
 
 
 
 
45 
  
 xv 
Clues to transmission—From source attribution to real-time 
tracking using pathogen genomes 
Daniel J. Wilson. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
46 
  
Detection of proteins homologous with HIV-1 antigens in bacteria 
of HIV positive patients 
Vladimir Zajac, Michal Mego, Lenka Wachsmannova, Zuzana 
Adamcikova, Vladimir Holec, Viola Stevurkova, Vladimir Krcmery. 
Presenter affiliation: Cancer Research Institute, Bratislava, Slovakia. 
 
 
 
 
47 
 
 
TUESDAY, September 14—9:00 AM 
 
 
SESSION 5 BACTERIA 
 
Chairperson: N. Day, Mahidol Oxford Tropical Medicine Research Unit  
  (MORU), Bangkok, Thailand 
J. Vinetz, University of California, San Diego, USA 
 
 
Nick Day. 
Presenter affiliation: Mahidol Oxford Tropical Medicine Research Unit 
(MORU), Bangkok, Thailand. 
 
  
Multistrain analysis of Anaplasma 
Anthony F. Barbet, Basima Al-Khedery, Michael J. Dark, Ulrike G. 
Munderloh. 
Presenter affiliation: University of Florida, Gainesville, Florida. 
 
 
 
48 
  
Intracellular parasitism, the driving force of evolution of 
Legionella pneumophila and Legionella longebachae 
Carmen Buchrieser. 
Presenter affiliation: Institut Pasteur, Paris, France. 
 
 
 
49 
  
Hypervirulent Chlamydia trachomatis clinical strain is a 
recombinant between lymphogranuloma venereum (L2) and D 
lineages 
Naraporn Somboonna, Raymond Wan, David M. Ojcius, Matthew 
Pettengill, Sandeep Joseph, Alexander Chang, Ray Hsu, Timothy D. 
Read, Deborah Dean. 
Presenter affiliation: CHORI, Oakland, California; University of 
California at Berkeley, Berkeley, California. 
 
 
 
 
 
 
 
50 
  
 xvi 
Inferring leptospiral pathogenicity through whole genome 
analysis 
Joseph M. Vinetz, Michael A. Matthias, Jessica N. Ricaldi. 
Presenter affiliation: UCSD, La Jolla, California. 
 
 
 
51 
  
Transcriptional profiling of Mycobacterium tuberculosis drug 
sensitive survivors of drug treatment identifies a regulator of 
persistence 
Brian Weinrick, William Jacobs, Jr. 
Presenter affiliation: Howard Hughes Medical Institute at Albert 
Einstein College of Medicine, Bronx, New York. 
 
 
 
 
 
52 
  
Analysis of the Neisseria meningitidis capsule 
Odile Harrison, Holly Bratcher, Keith Jolley, Heike Claus, Ulrich Vogel, 
Mike Quail, Stephen Bentley, Ian Feavers, Martin Maiden. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
53 
  
Emergence of a Streptococcus agalactiae lineage hypervirulent in 
fish by reductive evolution 
Philippe Glaser. 
Presenter affiliation: Institut Pasteur, Paris, France. 
 
 
 
54 
 
 
TUESDAY, September 14—2:00 PM 
 
 
SESSION 6 PARASITES AND VECTORS 
 
Chairperson: T. Anderson, Southwest Foundation for Biomedical  
  Research, San Antonio, Texas, USA 
A. Das, / National Institute of Malaria Research (ICMR),  
New Delhi, India 
  
  
From genome sequence to forward genetic analysis of 
Schistosoma mansoni 
Claudia Valentim, Phil LoVerde, Charles Criscione, Claudia Carvalho-
Queiroz, Jason Tsai, Matt Berriman, Tim Anderson. 
Presenter affiliation: Southwest Foundation for Biomedical Research, 
San Antonio, Texas. 
 
 
 
 
 
55 
  
 xvii 
A genomic approach to Trypanosoma cruzi lineage-specific 
serology for Chagas disease. 
Tapan Bhattacharyya, Martin Llewellyn, Matthew Yeo, Michael Lewis, 
Andrew Falconar, Alejandro Luquetti, Michael A. Miles. 
Presenter affiliation: London School of Hygiene & Tropical Medicine, 
London, United Kingdom. 
 
 
 
 
 
56 
  
Maintenance and evolution of Plasmodium falciparum genetic 
diversity sustaining a low transmission malaria endemic in the 
Peruvian Amazon 
OraLee H. Branch, Patrick L. Sutton, Juan Carlos Castro-Gomez, 
Carmen R. Barnes, Gisely Hijar-Guerra. 
Presenter affiliation: New York University, New York, New York. 
 
 
 
 
 
57 
  
Schistosoma mansoni data integration and mining—
Characterization of new drug targets 
Adhemar Zerlotini, Laila A. Nahum, Luiza A. Almeida, Larissa L. Silva, 
Mariana C. Simões, Fabiano S. Pais, Raymond Pierce, Guilherme 
Oliveira. 
Presenter affiliation: FIOCRUZ-Minas, Belo Horizonte, Brazil. 
 
 
 
 
 
58 
  
Complex malaria epidemiology and evolutionary genomic 
understanding from Indian malaria parasites, vectors and humans 
Aparup Das. 
Presenter affiliation: National Institute of Malaria Research, New Delhi, 
India. 
 
 
 
 
59 
  
Origins and evolution of variable surface antigens in African 
trypanosomes 
Andrew Jackson, Andrew Berry, John Gamble, Nicola Corton, Heidi 
Hauser, Martin Aslett, Dave Barry, Christiane Hertz-Fowler, Matthew 
Berriman. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom. 
 
 
 
 
 
 
60 
  
The SRS superfamily of Toxoplasma gondii is large, diverse and 
dynamic 
James Wasmuth, Martin Boulanger, Michael Grigg, John Parkinson. 
Presenter affiliation: Hospital for Sick Children, Toronto, Canada. 
 
 
 
61 
  
 
 
 xviii 
TUESDAY, September 14—5:30 PM 
 
 
KEYNOTE SPEAKER 
 
Dominic Kwiatkowski 
Oxford University, Sanger Institute 
 
 
 
TUESDAY, September 14 
 
CONFERENCE BANQUET 
 
Drinks  6:30 PM  Dinner  7:30 PM 
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USE OF WHOLE GENOME SEQUENCING TO TRACK THE IN VIVO 
EVOLUTION OF ANTIMICROBIAL RESISTANCE IN ENTEROCOCCI 
 
Cesar A Arias  
 
University of Texas Medical School at Houston, Infectious Diseases, 
Houston, TX, 77030 
 
Enterococci are microorganisms with a particular ability to adapt to the 
environment and acquire antibiotic resistance determinants. Of particular 
concern is the worldwide dissemination of vancomycin-resistant 
enterococci (VRE), which has resulted in a major decrease in therapeutic 
options to treat enterococcal infections. Apart from vancomycin, VRE are 
usually resistant to ampicillin and exhibit high-level of resistance to 
aminoglycosides, three of the traditionally most useful anti-enterococcal 
antibiotics. Currently, the only bactericidal antibiotic with in vitro and in 
vivo activity against VRE available in clinical practice is daptomycin 
(DAP). Although DAP does not have an FDA-approved indication for the 
treatment of VRE, it is often used to treat VRE infections due to the lack of 
other options. However, the development of resistance during therapy of 
VRE is a major drawback for this antibiotic and can severely jeopardize the 
only bactericidal compound currently available with potential activity 
against enterococci, including VRE. There is an important vacuum in the 
knowledge related to the factors and mechanisms involved in the 
development of DAP-R in VRE. Thus, using whole-genome sequencing, we 
aimed to understand the genetic changes associated with the development of 
DAP-resistance using isolates recovered from the same patient during DAP 
therapy. In May 2004, a woman was admitted to a hospital in Indiana with 
bacteremia with a vancomycin-resistant E. faecalis. After the failure of 
various antibiotics, she was re-admitted with fever and bacteremia with the 
same organism which was susceptible to DAP with a minimal inhibitory 
concentration (MIC) of 1 µg/ml. Daptomycin was started but after ca. two 
weeks, the patient returned bacteremic. The organism recovered from the 
blood had the same pulsed field gel electrophoresis (PFGE) pattern as the 
previous isolate and identical susceptibilities to antibiotics, except that the 
daptomycin MIC was now 16 µg/ml (isolate R712). We acquired the S613 
and R712 isolates and performed comparative whole genome analysis of 
these isolates. A total of 53 non-synonymous changes in predicted proteins 
of R712 were found. None of the mutations in genes previously associated 
with non-susceptibility to daptomycin in other organisms (i.e. S. aureus) 
were identified in the VRE orthologs, suggesting that VRE utilizes a novel 
genetic strategy to develop resistance to DAP. These findings will be of 
paramount importance to understand the mechanism of in vivo DAP-
resistance in VRE and, thus, design future strategies to prevent its 
emergence and “protect” this useful antibiotic for clinical use 
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DIVERSITY AND EVOLUTION OF STAPHYLOCOCCUS AUREUS 
CLONAL COMPLEXES ACROSS SPACE AND TIME 
 
Ruth Miller1, Tanya Golubchik2, Daniel Wilson1, Helen Farr2, Martin 
Llewelyn3, Rory Bowden1,2, Hanna Larner1, John Paul3, Nick Price3, Nick 
Day1, Sarah Walker1, Tim Peto1, Derrick Crook1  
 
1University of Oxford, Nuffield Department of Medicine, Oxford, , United 
Kingdom, 2University of Oxford, Department of Statistics, Oxford, OX1 
3TG, United Kingdom, 3Brighton and Sussex University Hospital, , 
Brighton, , United Kingdom 
 
Much of UK S. aureus, especially methicillin-resistant S. aureus (MRSA), 
occurs in two clonal complexes; CC22 and CC30. Evidence is accumulating 
that next-generation sequencing can be used to investigate population 
structure, even at fine scales of time and space, where isolates tend to be 
indistinguishable using lower-resolution techniques such as multi-locus 
sequence typing and spa typing. We have used the Illumina GAII platform 
to generate whole-genome data (>50× mean coverage) for CC22 and CC30 
population samples comprising a total of >150 isolates separated in space 
(Oxford and Brighton) and time (1997-2007) to develop a snapshot of the 
population and molecular evolution of S.aureus in the UK. 
We used a mapping-based approach (Maq software), with a high false 
positive rate for variant detection, coupled with a new goodness-of-fit 
filtering algorithm with high specificity and sensitivity to detect variants in 
unique regions of the genome.  
In both CCs, methicillin-sensitive S. aureus (MSSA) was more diverse, and 
evidently ancestral to MRSA lineages. There is only evidence for one 
emergence of MRSA in each CC, in the sampled populations. CC30 is more 
diverse than CC22, and the CCs are each at different stages of their history, 
which is confirmed by epidemiological data. Clustering consistent with 
epidemiological reports implied a recent common origin of all isolates in 
recent MRSA outbreak(s) in Brighton. A lack of sharing of recently 
diverged clusters across space suggested that whereas there has been 
general spread of CCs across the UK, mixing is not fast enough to prevent 
the appearance of geographically specific types. 
Whole genome sequencing captures the diversity of closely related strains 
in a CC, providing a deeper history than investigation of a single ‘sequence 
type’. This allows us to build a picture of S. aureus evolution, including 
rates of spread and mixing between locations, as well as identifying 
emerging lineages that would not be distinguishable using lower resolution 
techniques. 
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HIGH-RESOLUTION GENOMIC TYPING OF CLOSTRIDIUM 
DIFFICILE FOR HOSPITAL-BASED TRANSMISSION STUDIES 
 
Rosalind M Harding1, Madeleine L Cule2, Tanya Golubchik2, Ann S 
Walker3, Daniel Wilson2, Camilla Ip2, Hanna Larner2, Teresa Street2, Ruth 
Miller3, Tim E Peto3, Kate E Dingle3, David Griffiths3, Derrick W Crook3, 
Rory Bowden2  
 
1Oxford University, Zoology and Statistics, Oxford, OX1 3TG, United 
Kingdom, 2Oxford University, Statistics, Oxford, OX1 3TG, United 
Kingdom, 3Oxford University, NIHR Oxford Biomedical Research Centre, 
Oxford, OX3 9DU, United Kingdom 
 
Ongoing advances in whole genome pathogen sequencing and 
bioinformatics have now reached a stage where we can envisage their 
application to analysis of hospital-based outbreaks. We apply these 
methodologies to study transmission of Clostridium difficile infection 
(CDI), the most important cause of hospital-acquired diarrhoea in the UK.  
 
C. difficile is a 4.3Mb anaerobic bacterium that is present in the gut of up to 
7% of healthy adults and 66% of infants, where it is kept in check by the 
normal intestinal flora. Some antibiotics can lead to the rapid multiplication 
of C. difficile, raising toxin levels that lead to diarrhoea and other 
gastrointestinal symptoms, which can be fatal. Increases in the rate and 
severity of nosocomial CDI between 2000 and 2008 have been attributed to 
the epidemic spread of a hypervirulent clone (ribotype 027).  
 
The aim of the current work is to use deep sequencing of whole C. difficile 
genomes to distinguish ward-based transmission clusters within strains that 
have been defined by multiple locus sequence typing (MLST). In the 
current study 190 genomes have been sequenced, representing bacterial 
isolates sampled from symptomatic patients in the Oxford Radcliffe 
Hospital Trust (2007-2009). Illumina (Solexa) 51 bp paired-end reads have 
been mapped to reference genomes. The genomes include technical 
replicates at two levels (same DNA preparation or same isolate with 
different DNA library preparations), and re-sampling from the same patient. 
Our results confirm the potential for reference-based mapping to provide 
high resolution sub-typing. Furthermore, they provide evidence for patient-
to-patient transmission events that can be distinguished from new infections 
of the same MLST strain within the same ward and month. We hope to use 
these results to apportion hospital cases of CDI to either, (i) local 
transmission chains or, (ii) independent introductions of CDI, which may be 
circulating in the community.  
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MUTATIONS UNDERLYING THE RECENT CLONAL EXPANSION 
OF A DOMINANT SUBCLONE OF THE MYCOBACTERIUM 
TUBERCULOSIS BEIJING GENOTYPE 
 
Kristin Kremer1, Anita Schuerch1,3, Rob M Warren2, Roland J Siezen3, Noel 
H Smith4, Dick van Soolingen1  
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Netherlands, 2Stellenbosch University, MRC Centre for Molecular and 
Cellular Biology, Cape Town, 7505, South Africa, 3Radboud University 
Nijmegen Medical Centre, NCMLS, Centre for Molecular and 
Biomolecular Informatics, Nijmegen, 6500 HB , the Netherlands, 
4Veterinary Laboratories Agency, Bovine Tuberculosis, Surrey, KT15 3NB, 
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The Beijing genotype family is an epidemiologically important sub-group 
of Mycobacterium tuberculosis. It has been suggested that the high 
frequency of the Beijing isolates in some areas could be explained by a 
selective advantage. Beijing strains however do not show uniform 
phenotypes, probably due to different sublineages within the Beijing clade. 
The emerging “Typical Beijing” lineage may have the ability to circumvent 
BCG-induced immunity.  
To investigate the phylogeny of the Beijing genotype of M. tuberculosis, the 
genome of six Beijing strains from three different countries was sequenced 
with next-generation sequencing. The phylogeny of these strains was 
established using single nucleotide polymorphisms (SNPs). The three 
Typical Beijing strains clustered very tightly in the phylogeny within other 
Beijing strains suggesting that Typical Beijing are a monophyletic lineage 
and resulted from recent diversification. Typing of 150 M. tuberculosis 
strains with a subset of the SNPs and comparison to a database of Beijing 
IS6110 restriction fragment length polymorphism types revealed that 79.6% 
of all Beijing strains belong to the Typical Beijing subclone, which 
indicates clonal expansion. To reconstruct genomic changes that are 
characteristic for all Typical Beijing strains and were derived from their 
most recent common ancestor the presence of SNPs were assayed in other 
Beijing strains.  
Typical Beijing strains are the result of a recent clonal expansion and we 
identified 53 SNPs that define the minimal set of polymorphisms for all 
Typical Beijing strains. Nonsynonymous polymorphisms in genes coding 
for the regulatory network were over-represented in this set of mutations. 
The only mutation in a 3R gene (DNA repair, recombination and 
replication) that was identified was a silent mutation. The possible 
consequences of these mutations which might have enabled Typical Beijing 
strains to circumvent the BCG-induced immunity and become a dominant 
clonal complex of M. tuberculosis, are discussed.  
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ESCHERICHIA COLI O157:H7 ISOLATES RELATED TO THE 2006 
SPINACH-ASSOCIATED OUTBREAK EXHIBIT DISTINCT 
TRANSCRIPTIONAL PROFILES AND PHENOTYPES: THE SPINACH 
BAG AS A SELECTIVE SOURCE 
 
Craig T Parker, Jennifer L Kyle, Michelle Q Carter, Maria T Brandl, Steven 
Huynh, Robert E Mandrell  
 
USDA, Agricultural Research Service, Produce Safety & Microbiology, 
Albany, CA, 94710 
 
Food-borne outbreaks of illness due to Escherichia coli O157:H7 linked to 
the consumption of ready-to-eat leafy vegetables are a mounting concern. 
The likely sources of pre-harvest contamination are soil and water that 
become contaminated via cattle or feral pigs in the proximity of the 
vegetable fields. In this study, we compared the transcriptional profiles of 
twelve isolates that possess the same PFGE pattern and are related 
temporally or geographically to the 2006 E. coli O157:H7 outbreak 
attributed to fresh spinach in the United States. These E. coli O157:H7 
isolates included three clinical isolates, five isolates from separate bags of 
spinach, and single isolates from soil, water, a cow and a feral pig. From 
stationary phase cultures, we observed the decreased expression of many 
RpoS-regulated genes including gadA, osmE, osmY, and katE, in all three 
clinical isolates and two spinach isolates as compared to the soil, water, 
cow, feral pig, and the other three spinach bag isolates. The decreased 
expression of several RpoS-regulated genes correlated with decreased 
resistance to acid stress (pH 2.5), oxidative stress (15 mM H2O2), and 
osmotic stress (2.5 M NaCl) in these isolates. The transcriptional and 
phenotypic differences of the spinach bag isolates of E. coli O157:H7 
suggest that certain variants within the bag retained characteristics of the 
pre-harvest isolates while other variants with altered expression and 
phenotype infected the human host. 
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PNEUMOCOCCAL PATHOGENESIS IN THE CONTEXT OF HIV - 
THE BIOLOGY AND THE GENOME  
 
Robert S Heyderman  
 
Malawi-Liverpool-Wellcome Trust Clinical Research Program, ., Chichiri, 
Blantyre 3, Malawi 
 
HIV seroprevelence in many sub-Saharan African countries, exceeds 10% 
of the overall population rising to over 30% in pregnant women. Increased 
carriage and susceptibility to disease by mucosal bacteria such as 
Streptococcus pneumoniae is one of the earliest manifestations of HIV 
infection. Although anti-retroviral therapy (ART) has been aggressively 
rolled out in many countries in the region, the risk of invasive infection by 
mucosal bacteria even in those well established on ART remains higher 
than in those that are uninfected. We have demonstrated numerous antigen 
specific T cell and B cell defects in anti-pneumococcal immune memory in 
asymptomatic HIV infected adults. Here we will explore ways in which 
changes in strain diversity driven by this early immune dysregulation 
impacts on pneumococcal pathogenesis and therefore disease. 
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VOLANT VIRUSES: METAVIROMIC STUDY OF A WEST AFRICAN 
BAT POPULATION 
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Kingdom 
 
Bats constitute a significant reservoir of pathogens that can spill-over and/or 
emerge in both animal and human populations. This is illustrated by past 
outbreaks of SARS and Ebola haemorrhagic fever in humans, as well as 
Hendra and Nipah virus diseases in humans, horses and pigs. Active 
surveillance in areas with a high risk of spill over to characterise the viral 
richness within bat populations is thus critical for determining the potential 
for the emergence of new and known viruses from these animals.  
Multiple geographical regions have been predicted as ‘hot-spots’ for 
infectious disease emergence from wildlife, including Ghana (West Africa). 
Here, we study a population of fruit bats that roosts in large numbers in 
close association with people in Accra, the capital city of Ghana, where they 
are also a source of bush meat. We have previously shown that this fruit bat 
population has neutralising antibodies against both henipaviruses and a 
Type II Lyssavirus.  
Next generation sequencing (NGS) technology has greatly enhanced 
sequencing capabilities and has proved a unique tool for detecting 
previously-uncharacterized viruses. We applied a NGS approach to detect 
viruses in the aforementioned Ghanaian fruit bat population and identified 
numerous novel viral sequences, including members of the Herpesviridae, 
Papillomaviridae, Picornaviridae and Poxviridae. We discuss the 
importance of these findings for our understanding of the process of viral 
emergence . 
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BIOINFORMATICS ANALYSIS OVER RECENTLY SEQUENCED 
ADENOVIRUSES STRAINS 53, 54 AND INTERMEDIATE 15-29-9 
CAUSING EPIDEMIC KERATO-CONJUNCTIVITIS OUTBREAKS IN 
JAPAN 
 
Gabriel Gonzalez1, Hidemi Watanabe1, Kanako Koyanagi1, Koki Aoki2, 
Hisatoshi Kaneko3  
 
1Hokkaido University Graduate School of Information Science and 
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Every year, there is an outbreak of a new EKC strain in Japan and several 
other cases worldwide. EKC stands for Epidemic Kerato Conjunctivitis, and 
it is produced by adenovirus affecting the conjunctive tissue in eyes 
resulting in an inflammation of the cornea and conjunctive. EKC is highly 
contagious and it has the tendency to occur in epidemics. From 54 known 
human adenovirus strains, only 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 14, 15, 19a, 22, 
37, 53 and 54 are related with EKC, but how they evolve and how they are 
related is still unknown. This study’s pursuit is obtaining more insights 
about how adenoviruses could evolve into new strains. With this purpose on 
mind, we analyzed recently sequenced strains of 53, 54 and an intermediate 
product between 15, 29 and 9; all of these isolated in Japan in the last six 
years. Our analyses included recombinant analyses looking for recombinant 
events signals, and next, using these signals, we created phylogenetic trees 
over different sections of aligned genomes based on suspected recombinant 
regions; this process allowed us to look for relationships between them and 
confirm or reject the possibility of recombination. As outcome, we found 
“hot spots” for recombinant events in genes coding penton, hexon and fiber, 
which are the main components of the virion’s capsid, and also in the E3 
region which mostly encode the proteins for disguising the infection from 
the immune system. Besides, we obtained evidence which supports an 
origin for these new strains as result of recombinant processes from 
previously identified strains, like 53 which evidence supports an origin from 
a recombinant process between 8, 22 and 37; also, 54 which seems to be 
originated from 8, 9, 19 and 22. All of these related with previous EKC 
outbreaks. For example, 8 was first reported and identified during the 50’s. 
This work can be the base for stating new questions regarding results of 
these recombinant events in the infection mechanisms or contagion 
symptoms. All this information could help us to identify necessary 
conditions behind recombinant events in adenoviruses which are reported to 
obtain some kind of variability through such method. 
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WHOLE VIRUS GENOME SEQUENCING AND THE TRACKING OF 
H1N1PDM INTRODUCTIONS AND VIRUS PERSISTENCE IN THE UK 
 
Gregory J Baillie1, Monica Galiano2, Steve Platt2, Richard Myers2, Rachael 
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Virus gene sequencing and phylogenetics can be used to study the 
epidemiological dynamics of rapidly-evolving viruses. With complete 
genome data, it becomes possible to identify and trace individual 
transmission chains of viruses such as influenza during the course of an 
epidemic. Using both capillary and next generation sequencing methods we 
sequenced 154 influenza H1N1v genomes from UK isolates from the first 
(128 isolates) and second (26 isolates) waves of the 2009 pandemic, and 
have used the sequences and their dates of isolation to infer the genetic 
epidemiology of the UK epidemic. We demonstrate that the UK epidemic is 
composed of many co-circulating lineages, of which at least 12 were 
exclusively or predominantly UK clusters. The estimated divergence times 
of two of the clusters pre-date the detection of H1N1pdm in the UK, 
suggesting H1N1pdm was already circulating in the UK before the first 
clinical case. Crucially, 3 clusters contain isolates from the second wave of 
infections in the UK, two of which represent chains of transmission that 
appear to have persisted within the UK between the first and second waves, 
demonstrating that whole genome analysis can track in fine detail the 
behaviour of individual influenza lineages during the course of a single 
epidemic or pandemic. Forensic approaches to evolution of circulating 
influenza lineages will assist the early detection of emerging antigenic 
variants 
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Viral diseases such as HIV/AIDS and Dengue have an enormous impact on 
human health worldwide. Despite this, application of new sequencing 
technologies to viral genomics has lagged. We are using genome sequence 
data to study how populations of single stranded RNA viruses, including 
HIV, DENV, WNV and HCV, evolve within infected individuals in 
response to host immune, therapeutic, and vaccine pressures. We have 
developed high-throughput sequencing, assembly and population profiling 
pipelines based on 454 and Illumina technology that are tuned to the 
specific needs viruses. These strategies can assemble full genome sequences 
and can quantify sequence diversity at each residue in the genome with 
unprecedented sensitivity.  
 
We can detect rare variants to below 1% frequency, revolutionizing our 
ability to accurately assess the earliest events in viral evolution. We have 
demonstrated effective assessment of genome-wide diversity during acute 
HIV infection, enabling rapid and affordable identification of the earliest 
cellular immune responses to HIV. This has allowed us to detect earlier 
evolutionary events, demonstrating, for example, that HIV cytotoxic T-
lymphocyte (CTL) escape can occur much faster than previously known. In 
addition, we have shown that the extent of intra-host diversity in 
Flaviviruses such as DENV and WNV is different between these closely 
related viruses with the latter exhibiting greater genetic diversity. The 
results presented here demonstrate the power of scalable, next generation 
sequencing-based methodologies as a genome-wide and unbiased global 
approach to profiling genomic diversity in intra-host populations of single 
stranded RNA viruses. This project was funded by the NIAID NIH, Dept. 
HHS (Contract No. HHSN272200900006C) and the Gates Foundation.  
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DENGUE IN VIETNAM : GENOMICS OF THE VIRUS - HOST 
INTERACTION  
 
Cameron Simmons  
 
Oxford University Clinical Research Unit , Hospital for Tropical Diseases, 
Ho Chi Minh City, District 5,, Vietnam 
 
Dengue is a major public health problem in Asia and Latin America. The 
ecology of dengue viruses is constantly changing, with pronounced 
oscillations in both serotype and genotype prevalence in endemic settings. 
To explore this in detail, genome sequences of ~1000 DENV sampled 
between 2001 and 2008 coupled with phylogeographic techniques has 
allowed us to define the spatial and temporal dynamics of virus trafficking 
within and between communities, and between countries. Strikingly, a 
genotype replacement event within DENV-2 began in 2003, with an Asian 
1 lineage virus replacing the resident American/Asian lineage and 
precipitating a major increase in disease incidence that was associated with 
higher viraemia levels in patients. The implications of this for vector control 
activities and vaccine implementation will be discussed.  
 
In children, dengue shock syndrome (DSS) is the most common life-
threatening complication. Predicting patients who may develop DSS may 
improve triage and treatment. Strikingly, the only differences in the 
transcriptional signatures of early DSS and uncomplicated dengue cases 
was the greater abundance of several neutrophil-associated transcripts in 
patients who progressed to DSS, a finding supported by higher plasma 
concentrations of several canonical proteins associated with neutrophil-
degranulation (BPI, ELA2, DEF1A). Collectively, these data suggest an 
hitherto unrecognised association between neutrophil activation, 
pathogenesis and the development of DSS and point to future strategies for 
guiding prognosis.  
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OCCULT HEPATITIS C VIRUS INFECTION: THE PAKISTAN 
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BACKGROUND: Occult hepatitis C infection should be considered when 
diagnosing patients with a liver disease of unknown etiology. 
AIM: The aim of the present study was to determine the presence of HCV 
RNA in the liver biopsies of patients with abnormal liver tests but without 
detectable serum HCV RNA and anti-HCV antibodies in sera.  
METHOD: Liver biopsies and whole blood of total 31 patients who were 
negative for anti-HCV antibodies with elevated liver function tests were 
received at Division of Molecular Virology National Centre of Excellence 
in Molecular Biology, University of the Punjab Pakistan from January 2002 
to June 2009 for the detection of HCV RNA. HCV RNA status of the 
subjects was tested by reverse-transcription polymerase chain reaction (RT-
PCR) and quantified using SmartCycler II real-time PCR, in their liver 
biopsies, sera and peripheral blood mononuclear cells (PBMCs). HCV 
genotyping was carried out in HCV RNA positive samples using type-
specific PCR. 
RESULTS: HCV RNA was detected in liver-biopsy specimens from 23 
(74.2%) of the total 31 patients negative for anti-HCV antibodies and 
undetectable serum HCV RNA. HCV RNA of both negative and positive 
polarity was found in the livers of 8 (25.8%) patients. Genotyping analysis 
showed that 65% patients were infected with HCV 3a, 17% with 3b, 13% 
with 1a and 4% patients were found with untypable genotype. In a 
multivariate logistic regression model, patients having previous history of 
sharing needles, presence of steatosis, elevated liver enzymes, history of 
previous surgeries, male sex, age above 30 years and with liver fibrosis 
stage F1 were significantly associated with the presence of occult HCV 
infection. 
CONCLUSIONS: Patients with elevated liver enzymes and negative HCV 
antibodies and negative serum RNA may have intra-hepatic HCV RNA. 
The chance of occult HCV infection increases if the patient has previous 
history of sharing needles, elevated liver enzymes, history of previous 
surgeries, male sex and above 30 years of age. 
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POSITIVE SELECTION OF HIV HOST FACTORS AND THE 
EVOLUTION OF LENTIVIRUS GENES. 
 
Katarzyna Bozek, Thomas Lengauer  
 
Max Planck Institute for Informatics, Computational Biology and Applied 
Algorithmics, Saarbrücken, 66123, Germany 
 
Phylogenetic studies have shown that HIV emerged in humans through at 
least eleven cross-species transmission events of simian immunodeficiency 
virus (SIV) from non-human African primates. SIV infection of African 
non-human primate host species (including sooty mangabeys, African green 
monkeys, mandrills, and several others) is non-pathogenic despite high 
levels of viremia. Different levels of pathogenicity of immunodeficiency 
viruses in their host species as well as the lack of adaptation to their non-
natural species show how interspecies differences can impact viral 
infectivity and drive virus adaptation. Positive selection of rapidly evolving 
immune system genes reflects the evolution of the host defense in response 
to various infections and can be a marker of factors relevant for infection. 
 
Our comparative and evolutionary analysis of 1439 HIV-interacting genes 
of four primate species and 175 lentivirus genomes points to specific host 
factors of high genetic variability that could account for differences in 
susceptibility to disease and indicate specific mechanisms of host defense 
and pathogen adaptation. We find that the largest amount of genetic change 
occurs in genes coding for cellular membrane proteins of the host as well as 
in the viral envelope genes suggesting cell entry and immune evasion as the 
primary evolutionary interface between host and pathogen. We additionally 
detect the innate immune response as a gene functional group harboring 
large differences among primates that could potentially account for the 
different levels of immune activation in the HIV/SIV primate infection. We 
find a significant correlation between the evolutionary rates of interacting 
host and viral proteins pointing to processes of the host-pathogen biology 
that are relatively conserved among species and to those undergoing 
accelerated genetic evolution.  
 
Many of the proteins identified in our study are not SIV/HIV-specific but 
interact with a variety of pathogens (dengue, hepatitis, rhinovirus, 
tuberculosis, ebola, etc). Thus these results not only further the 
understanding of the interaction of primate hosts with lentiviruses but 
potentially also offer insights into other host-pathogen systems. Individual 
host factors pointed to by our analysis might merit further study as potential 
targets of antiretroviral therapies. 
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Studies of microbial pathogenesis and drug resistance have relied heavily 
on analyses of specific clones and their genetic determinants of virulence. It 
is often difficult to apply this deterministic approach to the study of RNA 
viruses, which by virtue of their very high mutation rates, exist as a 
complex mixture of mutants. Ensembles of mutants rather than individual 
clones maintain viral genetic information, and a growing body of evidence 
indicates that the structure and composition of viral populations determine 
their phenotype. Theoretical models further suggest that the location of 
populations within genetic sequence space can profoundly influence the 
evolvability of viral populations. We have directly tested this hypothesis 
using three different strains of poliovirus, a prototypical RNA virus with 
evolutionary dynamics similar to those of many emerging viruses. 
Compared to the wild type reference strain, the two variant polioviruses, 
Max and SD, encode 566 and 934 synonymous mutations, respectively, 
within the viral capsid. While all three viruses have identical GC content, 
codon usage, and amino acid consensus, they occupy distinct regions of 
sequence space and will give rise to genetically divergent populations. We 
show that wild type, Max, and SD replicate with similar kinetics and 
express nearly identical levels of protein – recognized correlates of viral 
fitness. Despite these similarities, direct competition assays indicate that SD 
is much less fit than wild type, and Max is slightly superior. Analyses of 
fitness variance and mutagen sensitivity suggest that SD is less fit because it 
gives rise to a population of mutants with lower average fitness than wild 
type. We are using next generation sequencing to define the mutant 
spectrum of all three viral populations and determine how sequence space 
influences viral phenotype and adaptability. We will also present 
pathogenesis data from a transgenic mouse model. Because the evolutionary 
dynamics of poliovirus closely resemble those of other RNA viruses, our 
results have profound implications for understanding the behavior of many 
emerging infectious agents. 
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UNDERSTANDING SELECTIVE PRESSURES ON ARBOVIRUSES 
USING EXPERIMENTAL IN VIVO PASSAGE OF FLAVIVIRUSES  
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West Nile virus (WNV) and St. Louis encephalitis virus (SLEV) are 
flaviviruses (Flaviviridae), which are predominantly maintained in an 
enzootic transmission cycle between mosquitoes and birds. SLEV was the 
major cause of epidemic flaviviral encephalitis in the U.S. prior to the 1999 
introduction of WNV. Recently, the level of activity and geographic 
dispersal of SLEV have been significantly more limited than WNV, the 
former sporadic and focal, while WNV remains highly active and is now 
widespread throughout the Americas. The need for arboviruses to replicate 
in disparate hosts is thought to result in constraints on both evolution and 
host-specific adaptation. This predicts that arboviruses are generalists, with 
a cost of suboptimal adaptation to each individual host. If cycling is the 
cause of genetic stability observed in nature and arboviruses lack host 
specialization, than sequential passage should result in both the 
accumulation of mutations and specialized viruses better suited for 
replication in that host. Our previous in vitro studies suggest that WNV and 
SLEV may differ in their capacity for both genetic change and host 
specialization, and in the costs each accrues from specializing. In an attempt 
to clarify how these selective pressures contribute to epidemiological 
patterns of WNV and SLEV, we evaluated both genetic and phenotypic 
changes for WNV and SLEV following sequential passages in natural hosts, 
either Culex pipiens mosquitoes or chickens. Analysis of intrahost genetic 
diversity of SLEV during passage demonstrates that, similar to WNV, the 
size of the mutant spectrum is host-dependent and the capacity for genetic 
change is large. Despite this, a general lack of fixed consensus changes in 
either virus resulted from passage in either host, a result that contrasts with 
the idea that significant constraints on evolution exist. Passage of WNV in 
mosquitoes resulted in adaptation to mosquitoes in terms of both infectivity 
and replication kinetics, yet did not result in any apparent fitness cost in 
chickens. A lack of both genetic and phenotypic change was measured in 
WNV following 20 passages in chickens, suggesting further host 
specialization was not attainable. Similarly, no additional specialization to 
mosquitoes was attainable for SLEV following 20 passages in mosquitoes 
and, although a strain more infectious to chicks did emerge from chick 
passage of SLEV, no cost was measured for this strain in terms of mosquito 
infectivity. These results suggest that these viruses may be capable of 
residing at or near maximum fitness peaks in both hosts and that ultimately, 
coadaptation may be attainable for arboviruses with minimal cost in either 
host. 
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NOVEL HANTAVIRUS DETECTED IN YUNNAN RED-BACKED 
VOLE,EOTHENOMYS MILETUS 
 
Yun-zhi Zhang, Zheng-li Shi  
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Hantaviruses cause two main human zoonoses, hemorrhagic fever with 
renal syndrome (HFRS) in Asia and Europe, and hantavirus pulmonary 
syndrome (HPS) in North and South America. Rodents are natural 
reservoirs of hantavirus. Long-term surveillance of HFRS is necessary for 
preventing the diseases transmission from animal to human. In this study, 
330 rodents covering 12 species were captured in hantavirus endemic areas 
(Luxi county), Yunnan province, China, during autumn of 2009 to the 
spring of 2010, and detected for the infection of hantavirus. Among the 
samples, 23 out of 133 Eothenomys miletus, 3 out of 96 Rattus flavipectus 
and 2 out of 25 Rattus nitidus showed positive by immunofluorescence 
assay (IFA). However, the virus was detected only in 23 Eothenomys 
miletus. The sequences of small fragment (S), encoding the nucleocapsid 
protein, was obtained from virus-infected animal tissue. The sequence 
comparison of S fragment with other hantavirus indicated that the 
hantaviruses from Eothenomys miletus are more closer to Tula virus (88% 
in amino acid sequence). Moreover, the hantavirus sequences detected from 
positive samples displayed genetic diversity. To our knowledge, this is the 
first discovery of Tula virus in Eothenomys miletus. 
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INFECTION IN RURAL POPULATIONS IN CAMEROON 
 
Judith N Torimiro1, Nathan D Wolfe2, Donald S Burke3, Jean K Carr4, 
Michael Dean5, Joseph Sodroski6  
 
1 University of Yaounde I , Faculty of Medicine and Biomedical Sciences, 
Yaounde, 03077, Cameroon, 2Global Virus Forecasting Initiative, 
Epidemiology, San Francisco, CA, 94104, 3Graduate School of Public 
Health, International Health, Bradford, PA, 16701, 4Institute of Human 
Virology, Epidemiology, Baltimore, MD, 21201, 5National Cancer Institute, 
Frederick, MD, 21702, 6Dana-Farber Cancer Institute, Boston, MA, 02115 
 
HIV infection in Cameroon is driven by several genetic variants. However, 
this old infection represents less than 3% of the rural populations in the 
southern rainforest region of Cameroon. HIV-1 gains entry into a competent 
cell through receptors (CD4 and co-receptor CCR5) to continue its 
replication process. This process can be controlled by both virus and host 
genetic factors that may lead to induction of disease or virus clearance. We 
investigated the anti-viral activity of TRIM5 alpha which is primate 
species-specific and which shows different degrees of potency to block the 
uncoating step in retrovirus replication, CCR5 ∆32 frequency as well as 
HIV Type 1 genetic variants that circulate in these communities. 
METHODS: Full length HIV-1 genotyping was performed by sequencing 
and phylogenetic analysis using the MEGA 3 software, CCR5 genotyping 
by Restriction Fragment Length Polymorphism assay and TRIM5 alpha 
genotyping by sequencing and TRIM5 alpha protein analysis RESULTS: 
The most prevalent HIV-1 variants identified were CRF02_AG (66.5%) and 
unique recombinant forms (10.4%) and less so Subtype A2, D, F2, G, 
CRF01_AE, CRF11_cpx, CRF13_cpx, CRF18_cpx,CRF22_01A1, 
CRF25_cpx, and CRF37_cpx. No individual with CCR5 ∆32 allele was 
identified. A rare allele of TRIM5 alpha with negative-dominant effect on 
its anti-viral activity was identified among 4.2% of pygmies in this study. 
CONCLUSION: Data on these human genes may be useful in explaining 
zoonotic retroviral infections and possible targets for anti-viral drug 
development and provide clues to our understanding of population risks to 
emerging viral infections. 
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Mycobacterium tuberculosis (Mtb) poses a global health catastrophe that 
has been compounded by the emergence of highly drug resistant Mtb 
strains. In Mtb, all drug resistances are the result of chromosomal mutations 
and depend on the bacterium’s capacity for mutation during the course of 
infection. We used whole genome sequencing (WGS) to directly compare 
the accumulation of mutations in Mtb isolated from cynomolgus macaques 
with active, latent and early reactivation disease. Based on the distribution 
of single nucleotide polymorphisms (SNPs) observed, we calculated the 
mutation rates for these disease states. Our data suggest that during latency, 
Mtb acquires a similar number of chromosomal mutations as would be 
expected to emerge in a logarithmically growing culture over the same 
period of time despite reduced bacterial replication during latent infection. 
The pattern of polymorphisms indicates that the mutational burden in vivo 
is due to oxidative DNA damage that occurs in the host environment. Thus, 
we demonstrate that during clinical latency, Mtb continues to acquire 
chromosomal mutations and provide an explanation for the observation that 
isoniazid (INH) monotherapy for latent tuberculosis is a risk factor for the 
emergence of INH resistance. 
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The importance of homologous recombination in Streptococcus pneumoniae in 
the evolution of the species is appreciated.  
 
In a first step, an analysis of 1,930 pneumococcal genotypes from six 
housekeeping genes highlighted however that homologous recombination does 
not seem to affect the species homogeneously. A subset of strains showed 
evidence of enhanced admixture with other populations, and was significantly 
enriched in lineages resistant to a range of antibiotics. It is hypothesized that 
these strains were the result of a history of hyper-recombination, which is 
expected to introduce both divergent alleles and resistance determinants at an 
elevated rate. 
 
Subsequently, we analyzed 215 complete full-length genomes from a lineage 
suspected of having experienced a history of hyper-recombination. The 
Pneumococcal Molecular Epidemiology Network clone 1 (PMEN1) lineage is 
typically identified as being penicillin resistant and serotype 23F. The sample 
was mostly composed of a single lineage, ST 81, and close variants as defined 
by commonly applied molecular typing methods (see also related abstract by 
Croucher et al). 
 
Recombination events were identified with a moving window χ2 test; as well as 
being surprisingly frequent, affecting over half the genome within this sample 
alone, and with some identified hotspots, recombination events were not 
distributed evenly over a genealogy constructed from non-recombinant 
sequences. After characterizing the size and frequency distribution of 
recombination events, our model identified at least eight braches within the 
phylogeny affected by hyper-recombination events, within which 
recombinations were not only more frequent but also uncharacteristically large. 
 
These results shed new light on the nature and dynamics of evolution within 
Streptococcus pneumoniae. One might expect selection to rapidly purge or fix 
selectively significant genetic changes, and so it appears surprising that 
clinically and selectively important traits such as antibiotic resistance should 
maintain a long-term association with hyper-recombination within whole 
subpopulations co-exisiting with other strains. We hypothesise that these 
subpopulations may be adapted to specific niches where co-infection and thus 
recombination is more common. 
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Shigella sonnei is the leading cause of bacterial dysentery (Shigellosis) in 
industrialised countries, while Shigella spp. flexneri, dysenteriae and boydii 
occur frequently in developing countries. In Ho Chi Minh City, Viet Nam, 
the proportion of Shigellosis caused by S. sonnei has shifted from 30% in 
1995-1996 to 70% in 2007-2008 (Vinh et al, 2009, BMC Infect Dis 9:204). 
This shift coincided with increases in the severity and drug resistance of S. 
sonnei infections. 
 
We generated whole genome sequence data for 91 S. sonnei isolated from 
patients Ho Chi Minh City during three study periods, 1995-1996 (N=21), 
2000-2002 (N=38) and 2006-2008 (N=39), using multiplex paired-end 
sequencing on the Illumina platform. We used bwa to identify single 
nucleotide polymorphisms (SNPs) between the Vietnamese isolates and two 
available reference sequences. 
 
We identified 2,800 SNPs in total, which were used to construct a 
phylogenetic tree. Eighty-three (91%) of the Vietnamese isolates formed a 
single clonal complex in which each isolate differed from all others by no 
more than 100 SNPs. The clonal complex consisted of three clonal groups 
(A, B, C), which arose successively (A->B->C) and were closely associated 
with year of isolation. The successive clonal groups account for the 
increasing trends in drug resistance observed between study periods, with 
increasing rates of extended spectrum beta-lactamase (ESBL) production 
(A-0%, B-5%, C-30%) and resistance to nalidixic acid (A-0%, B-20%, C-
95%). The succession of clones also accounted for the increased disease 
severity, with average length of hospital stay rising from 2 to 4 to 6 days 
and average total duration of illness rising from 4 to 5 to 6 days. Distance 
from the root of the phylogenetic tree was linearly correlated with year of 
isolation, with an average accumulation of 3.2 SNPs per genome per year. 
The clonal groups were each defined by multiple SNPs and other variants, 
which may be associated with the differences in disease severity or drug 
resistance observed between the groups.  
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Many infectious diseases have emerged and circulated around the world 
with the development of human civilizations and global commerce. 
Anthrax, plague and tularemia are three such zoonotic diseases that have 
been intensely studied through genome characterization and 
phylogeographic analyses. A few highly fit genotypes within each of the 
causative species represent the vast majority of observed disease cases. 
Mutational and selective forces working together create highly adapted 
pathogens, but this has to be coupled with ecological opportunities for 
global expansion. In contrast, Burkholderia pseudomallei is an 
opportunistic pathogen (melioidosis) with a large environmental reservoir. 
Infecting humans, and perhaps all higher animals, is relatively unimportant 
in the evolution and ecology of this highly non clonal bacterium. But, 
global dissemination of the pathogen has occurred and population genetic 
patterns are still discernable using statistic, rather than cladistic, analyses. 
Population genetic analysis provides the underlying basis for both 
molecular epidemiology and microbial forensics. A basic understanding of 
the inheritance mechanisms for each pathogen is essential for validating 
model assumptions. 
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Current observations of the population genetics and evolution of 
Campylobacter jejuni and Campylobacter coli have proved instructive in 
modeling divergence in bacteria. In a recent paper we described a change in 
the patterns of inter-species gene flow which are consistent with 
despeciation of these bacteria. This has generated considerable interest and 
positioned the genus at the centre of research into fundamental biological 
processes that generate and maintain bacterial species. Here we describe a 
genomics approach to investigate the patterns of gene flow among 
Campylobacter populations, by identifying homologous and non-
homologous recombination in 30 sequenced genomes. A whole genome 
neighbor-joining genealogy confirmed the 3-clade structure within C. coli 
and analysis using a progressive Mauve backbone output to quantify the 
“core” and “pan” genomes demonstrated that while the average genome size 
(approximately 1.6 Mb) varies little between groups, C. coli clade 1 has a 
smaller core genome and larger pan genome per strain than the other two C. 
coli clades or C. jejuni. Probabilistic assignment of nucleotide 
polymorphisms (239543) to species, using STRUCTURE, demonstrated 
that, while C. coli clades 2 and 3 and C. jejuni recombined mostly within 
species, as much as 20% of the C. coli clade 1 genomes is of C. jejuni 
origin. Further analysis identified 2237 homologous and 590 non-
homologous recombination events (>50 bp) within C. coli clade 1, using 
CLONALFRAME and GENOPLAST respectively. The results supported 
the hypothesis that this is largely due to recent recombination between C. 
jejuni and C. coli clade 1. This is consistent with our previous findings 
concerning species convergence. 
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With the rapid advances in sequencing technologies the ability to produce 
many complete bacterial genomes cost effectively allows for an 
unprecedented view into the evolution of bacterial populations. We have 
applied whole genome sequencing to 36 clinical isolates of community 
acquired methicillin resistant staphylococcus aureus (MRSA). The isolates 
were selected from infected individuals with a broad array of clinical 
presentations allowing us to look at genomic differences that may play a 
role in pathogenesis and drug resistance. We sampled individuals without 
co-infection, compromised immune systems, and other phenomena that may 
confound our conclusions. We ultimately find evidence for selection within 
the MRSA genome over time as well as for the potential role of particular 
pathways and processes that mediate pathogenesis. The results of this study 
lay a foundation for large-scale whole genome association studies of 
infectious diseases that will be able to highlight pathways and single genes 
directly influencing virulence 
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In today’s world, more then ever, Public Health is a global issue. While on 
one side globalization is seen as a tool to overcome poverty and diseases, on 
the other it is felt as a threat to be counteracted. Whatever the view on 
globalization is, the consensus is that it affects Public Health, thus a more 
comprehensive approach should consider the global perspective (Global 
Public Health), beyond concerns of nations.  
Global Public Health-related problems consist of both health matters, as 
global issues indirectly related to, but affecting Public Health. In the former 
group fall the HIV and malaria epidemics; while in the latter rural 
development and climate change.  
Within Public Health, the field of Public Health Genomics (PHG) combines 
knowledge from genetic science with insights from population and social 
sciences, and is defined as the effective translation of genome-based 
knowledge for the benefit of population health. 
This study aims at evaluating the potential of PHG to face existing global 
issues, by exploring the integration of genome-based knowledge and 
technologies into Global Public Health. 
Existing evidence supports the successful implementation of PHG in some 
Public Health areas, as molecular epidemiology, diagnostics and 
vaccinology. In addition, advances in genomics could be used in an even 
wider range of fields to tackle Global Health. This is the case of 
nutritionally enhanced food, environment bioremediation and disease 
resistant-crops. Additionally, PHG can improve Global Health by means of 
genome-based information of basic mechanism of diseases, thus guiding the 
development of future health interventions. Such advances can influence the 
prevention, diagnosis and treatments of some of the major Global Health 
treats, as malaria, tuberculosis and HIV.  
Furthermore, a key reason to invest in genomics and integrate its knowledge 
into Global Public Health is to prevent the increase in the existing gap in 
genome-based research and use of genome-based information around the 
globe. Such “genomic divide”, if unchecked, could lead to even greater 
disparities in Global Health.  
Finally, implementing PHG should be seen as a mean of capacity and 
infrastructure building and scientific development in countries around the 
world. 
In conclusion, Global PHG has the potential to meet the Public Health 
needs of both developed and developing countries. In the implementation of 
Global PHG countries’ health needs and known benefits of genome-based 
information and technologies should be carefully assessed. Finally 
integration of PHG into Global Health will allow a fairer use of scientific 
advances around the globe and the reduction of the genomic divide. 
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Trypanosoma cruzi is the causative agent of Chagas disease. The genome 
sequence of the T. cruzi reference strain CL Brener was published in 2005, 
and has greatly facilitated research into this disease. However, there are 
many T. cruzi evolutionarily diverged lineages with different geographical 
distributions, hosts and possibly also different clinical manifestations. We 
have therefore performed draft genome sequencing of the T. cruzi I isolate 
Sylvio X10/1 and performed comparative analysis to CL Brener (TcVI). No 
lineage specific genes could be identified for either strain. A large amount 
of allelic polymorphism was present, including nucleotide polymorphisms, 
small insertion-deletion events and microsatellites. Many genes show 
evidence of positive selection. The overall repeat content of Sylvio X10/1 is 
lower than that of CL Brener, including repeated genes, and an analysis of 
sequence reads revealed a 9-30% divergence of the major surface antigen 
family genes. Estimation of the number of genes present in the large T. 
cruzi gene families indicates that the mucin multigene family is the most 
diverged and expanded in these two genomes. 
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Emergence and spread of chloroquine-resistant malaria parasites is one of 
the major problems in the treatment and prophylaxis of malaria. Evidences 
so far have suggested the role of the Pfcrt gene, located on chromosome 7, 
in conferring resistance against chloroquine (CQ). In particular, an amino 
acid mutation in the 76th position of the Pfcrt protein has been directly 
implicated. However, several bodies of evidences have directly or indirectly 
suggested that Pfcrt might not be the sole gene governing chloroquine 
resistance (CQR) in P. falciparum. Among all this, observed linkage 
disequilibrium between the Pfcrt and Var S4 region suggest that genes other 
than the Pfcrt present in this region (alone or in association with Pfcrt) 
might also govern CQR in P. falciparum. To test this hypothesis we 
followed evolutionary genomic approaches to scan the 530 kb DNA 
fragment of Chromosome 7 encompassing the Pfcrt and the var genes 
including seven other transporter genes tandemly placed as cluster (CG3, 
CG4, CG8, CG1, CG6, CG2 and CG7). We designed primers to amplify 
and sequence 10 non-coding DNA fragments (one marker each in 10-15Kb) 
present in intergenic regions in 15 CQ sensitive (CQS) and an equal number 
of P. falciparum CQR isolates from India. Results on DNA polymorphism 
and summary statistics were different for CQS and CQR types. Most 
significantly, the patterns of nucleotide diversity across the 10 fragments 
were quite dissimilar (and opposite) for CQR and CQS populations. While 
no definite pattern could be observed in CQS isolates, in the CQR isolates, 
nucleotide diversity was found to dip suddenly and reached almost zero (a 
characteristic feature of a recent “selective sweep”) while approaching the 
CG2 gene, but again took a leap at the next fragment (located at the end of 
the CG2 gene). Thus to verify if CG2 gene is also included under the 
“selective sweep” region, we sequenced four different fragments of CG2 
gene in both the CQS and CQR types and find very meager nucleotide 
diversity in CQR types in comparison to the CQS types, signifying that the 
CG2 gene might be under the influence of positive natural selection in CQR 
but not in the CQS isolates. Since the CG2 gene has earlier been implicated 
in chloroquine resistance in P. falciparum, the role of CG2 gene in 
chloroquine resistance might not be ruled out. 
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The family Simuliidae (Black Flies) is generally regarded as the second 
most significant insect disease and pest taxon inflicting humankind. The 
biting adult females transmit a wide variety diseases, including 
onchercercisis, leishmaniasis, and many arboviruses. Much of the health 
and economic impact of the family is also caused by sheer mass biting, 
causing severe health problems in the tropics, and heavy economic losses to 
agriculture world-wide. In spite of this medical and economic impact, 
molecular studies of this family have languished since the early DNA-DNA 
reassociation kinetics analysis, largely because of the near impossibility of 
establishing laboratory colonies. Instead, cytogenomic analysis of natural 
populations have yielded a high resolution picture of the family-wide 
population structure unmatched in any other taxon. In the absence of 
(molecular) genetic maps, we have initiated a genomics project focusing on 
the only extant black fly colony (Simulium vittatum) with a transcriptome 
analysis (https://wiki.cgb.indiana.edu/display/grp/Simulium). To 
supplement the standard characterization of the transcriptome, we have used 
proteomic approaches such as 2D protein electrophoresis, post-translation 
modification studies and mass spectrometry. Using de novo sequencing ms-
ms data we have isolated ESTs corresponding to novel proteins of interest, 
focusing on novel silk, storage and reproductive proteins. We anticipate that 
genomic/proteomic approaches for non-laboratory organisms will find 
wide-spread use as genomic studies of arthropod disease vectors reaches 
past dependence on laboratory colonies into natural populations. 
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Introduction: 
The population structure of Campylobacter jejuni and C. coli has been well 
characterised by use of multilocus sequence typing (MLST) with 43 clonal 
complexes described to date. Association between some clonal complexes 
and isolation source has been exploited to identify the reservoir of origin of 
particular strains. However, several multi-host clonal complexes, notably 
sequence type (ST) 21 complex, which are large and diverse cannot be 
resolved by 7-locus typing. Our aim was to determine whether data from 
additional loci would provide further insight into Campylobacter population 
genetics, host association and evolution. 
 
Methods: 
Fragments of 14 housekeeping genes, either previously used in alternative 
Campylobacter typing schemes or employed in MLST schemes for other 
organisms, were sequenced from; (i) C. jejuni isolates from the predominant 
ST of the ST-21 complex (including ST-19, ST-21, ST-50, ST-51 and ST-
104), (ii) C. coli isolates from clades 1, 2 and 3, (iii) representative(s) of the 
central genotype of the other 42 clonal complexes. Genealogical analyses of 
the data included the use of ClonalFrame. 
 
Results: 
Allelic information from 14 loci increased the resolution of large multi-host 
complexes and subspecies C. coli clades. Isolates from 5 predominant STs 
of the multi-host ST-21 complex were sub-divided to create a total of 30 21-
locus STs on differences identified at between 10 and 2 of the 14 additional 
loci. ClonalFrame analysis confirmed the association between ST-48, ST-
206 and ST-21 complexes. 
 
Conclusions: 
Analyses of additional loci is informative in increasing resolution between 
isolates belonging to large multi-host clonal complexes. Further analyses of 
a larger data set is required to determine whether sequencing from more 
alleles is informative with respect to host-association. 
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Although most species in the genus Listeria are non-pathogenic, 
saprophytic (decomposing organic material) bacteria, two species—the 
dangerous foodborne microbe L. monocytogenes, and L. ivanovii—are 
highly virulent and able to cause severe disease in infected hosts. Both of 
these species carry homologous virulence genes, suggesting shared 
mechanisms of pathogenicity, but the avirulent species of Listeria also share 
some of the putative virulence genes, thus making the specific identification 
of pathogenic Listeria challenging. To better understand evolution of 
Listeria virulence at the genome level, and catalog the set of genes that may 
be critical for virulence, we used SOLiD™ system sequencing to generate 
draft genomes for seven strains representing Listeria species or subtypes for 
which genome sequences were not available. Comparative analyses of these 
draft genomes and six publicly available genomes suggested a relatively 
closed Listeria pan-genome with 2,032 core and 2,918 accessory genes, 
limited gene loss and acquisition with conserved genome size (between 2.8 
and 3.2 Mb), and a highly syntenic chromosome. Loss of multiple 
virulence-associated genes is a common feature of all non-pathogenic 
Listeria strains, although a consistent pattern of specific gene loss is not 
apparent. The data support a model in which modern Listeria species 
diverged, beginning in the Eocene, from a pathogenic common ancestor that 
contained key virulence genes, with emergence of saprophytic Listeria 
lineages occurring multiple times during the evolution of this genus. The 
genus Listeria thus provides an example of a group of bacteria that evolve 
through a loss of virulence rather than acquisition of virulence 
characteristics, as observed for many other infectious bacteria. While 
Listeria includes a number of species-like clades, many of these include 
subtypes or strains with atypical virulence-associated characteristics. The 
information obtained in this study will allow for the development of genetic 
and genomic criteria for pathogenic strain identification.  
 
* These two authors contributed equally 
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Salmonellosis is an important global public health issue and rapid detection 
of pathogenic bacteria in food supplies has become an increasing priority. 
The SOLiDTM System was used for whole genome sequencing of 16 less 
common human disease associated Salmonella serotypes to (i) expand our 
knowledge of the rfb locus and to support DNA-based approaches for 
serotyping and (ii) to characterize mobile elements and plasmids.  
 
In this study, the SOLiDTM 3 Plus System was used to sequence whole 
genomes of 16 different serovars of Salmonella. Mate paired libraries with 
approximately 1.5 kb inserts were constructed for each genome and beads 
were generated by emulsion PCR prior to deposition on an eighth of a slide. 
Sequencing was carried out on a SOLiDTM System at 25 base pairs for the 
R3 and F3 tags. After correcting errors in colorspace reads, de novo 
assembly was performed using the SOLiD de novo pipeline.  
 
On average, 28.5 million reads from each strain were generated for the F3 
and R3 tags. The deep read coverage ranged from 143 to 200 fold per 
nucleotide. De novo assembly of the Salmonella short reads resulted in 
2,345 contigs per genome. The sum of the length of the contigs is between 
4.7 Mb, which is comparable to genome sizes of previously sequenced 
Salmonella genomes. Widely distributed rfb genes wzx and wzy, encoding 
for an O-antigen export unit and O-unit polymerase are present in the rfb 
clusters associated with most Salmonella serogroups (except serogroups 
O:2(A), O:4(B), or O:9(D1), and represent possible targets for molecular 
serotyping. Mobile elements and plasmids were identified by finding 
scaffolds that do not match any Salmonella chromosome. Two different 
plasmids were identified in S. Montevideo: (i) a conjugative plasmid of 53 
kb encoding antimicrobial resistance genes and (ii) a 299 kb conjugative 
plasmid of the IncH12 incompatibility group. One IncI1 plasmid of 
approximately 120 kb and one element of approximately 91 kb were found 
in serotype Inverness; the 91 kb element shows characteristics of a mobile 
element, which was also identified in serotypes Rubislaw and Urbana. 
Putative IncI1 plasmids harboring virulence genes were identified in 
Mississippi and Urbana isolates. A serotype Montevideo isolate was found 
to contain two plasmids, one IncW plasmid carrying an integron class 1 
element that encodes sulfonamide and aminoglycoside resistance, and one 
IncH12 plasmid encoding resistance to several heavy metals, disinfectants, 
and tetracycline. 
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Salmonella is one of the leading causes of bacterial foodborne 
gastroenteritis worldwide. The over 2,500 Salmonella serotypes that exist 
can differ substantially in their geographic distribution, virulence, host 
adaptation and antimicrobial resistance. To date, few genome sequencing 
projects have studied the genetic determinants responsible for evolution of 
the Salmonella genus or the phenotypic features that distinguish different 
serotypes. We present the results of a genome sequencing project of 17 non-
typhoidal S. enterica isolates from human, animal and food sources, 
including serotypes Heidelberg, Newport, Kentucky, St. Paul, 
Schwarzengrund, Agona, Dublin, Javiana, Weltevreden, Hadar, Virchow, 
and I4,[5],12:i:-. 
Strains were selected to represent a variety of common serotypes and 
include isolate pairs from the same serotype that showed different 
antimicrobial resistance phenotypes (Newport, Schwarzengrund, 
Heidelberg, Kentucky) or that had previously been shown to belong to 
different sub-lineages within the same serotype (St. Paul, Newport). Using 
comparative genomics approaches, we identified large variations in the 
genome content of prophage regions and plasmid elements between and 
among the different serotypes - mobilome components, which are predicted 
to substantially impact the overall phenotypes of each serotype.  
To investigate potential mechanisms responsible for different phage and 
plasmid contents, we analyzed Clustered Regularly Interspaced Short 
Palindromic Repeat (CRISPR) elements found in each of the genomes. Our 
results show that inter- and intra-serotype phenotype variations are reflected 
by different sets of CRISPR elements. Furthermore, S. Newport and S. St. 
Paul genomes from different lineages within the same serotype are 
characterized by different sets of CRISPR spacer elements, possibly 
reflecting adaptation to varying plasmid and/or phage contents. 
Our results suggest that CRISPR elements play an important role in 
serotype evolution within the Salmonella genus with impact on virulence, 
antimicrobial resistance and host specificity and should be further examined 
in the future. 
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A clinical study in Japan strongly suggested that Helicobacter pylori is 
responsible for recurrence of gastric cancer. There have been hypotheses 
linking the genotype of East Asian H. pylori to the high incidence of gastric 
cancer in East Asia. In order to fully understand the East Asian strains, our 
group determined entire genome sequences of 4 H. pylori strains from 
Japanese patients by Sanger sequencing and compared them with the 6 
complete genome sequences. We analyzed ortholog relationships, 
phylogenies, horizontal transfers, gene gains and losses, and genome 
rearrangements. 
Potential macro-regional genome rearrangements were analyzed and 
rearrangement pathways were reconstructed by combination of regional 
inversion events. Even within the closely-related Japanese isolates, many 
genome inversions have occurred at various positions. Their recombination 
points were frequently linked to restriction-modification (RM) genes, which 
suggests their involvement. We also detected RM systems and genomic 
islands specific to the East Asian strains. In a Japanese strain, we found a 
genomic island with features of a prophage. This may be the first report of 
prophage-like region in H. pylori. Analysis of the other plastic regions and 
genes will also be reported. 
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With over 200 million people suffering from schistosomiasis, it is the 
second most significant tropical parasitic disease after malaria. Due to the 
absence of a vaccine, patients rely on the single anthelmintic agent 
praziquantel for treatment, which has worryingly led to fears of drug 
resistance. 
As expected for a complex metazoan parasite, schistosomes exhibit a high 
degree of gene regulation. Large-scale transcriptome studies have shown 
stage-specific, as well as gender-specific expression of multiple genes. 
DNA methylation-mediated gene silencing as a means of transcriptional 
control has evolved in higher eukaryotic organisms. While recent studies 
have established that schistosomes post-translationally modify histones and 
express small regulatory RNAs, no compelling evidence exists that 
demonstrates this parasite’s genome is methylated.  
However, the sequencing of the Schistosoma mansoni genome revealed the 
presence of key proteins involved in the DNA methylation machinery - a 
putative Dnmt2-like protein (SmDNMT2) as well as a Methyl-Binding-
Domain Protein (SmMBD). Expression analysis has shown that SmMBD 
and SmDNMT2 are developmentally co-regulated - suggesting an important 
role of DNA-methylation during lifecycle progression, intra-snail 
maturation and female biology.  
To provide preliminary evidence that the genome of this blood fluke is 
indeed methylated, methylation sensitive amplification polymorphism 
(MSAP) analyses were performed on various schistosome lifecycle stages. 
Here, cytosine methylation was detected in both free-living and parasitic 
life stages as well as in both sexes. Strikingly, culturing S. mansoni adult 
pairs in the presence of the DNA-methyltransferase inhibitor 5-Azacytidine 
(5-AzaC) resulted in a general decline of egg production with increasing 
drug concentration. Furthermore, MSAP analysis showed a change in 
methylation pattern after 5-AzaC treatment. Therefore, as the eggs are the 
primary cause of the pathology associated with schistosomiasis, targeting 
the DNA methylation system of the parasite could be an exciting treatment 
opportunity.  
Collectively these observations will contribute to a greater understanding of 
Platyhelminthes developmental biology, assist in the evolutionary 
reinterpretation of DNA methylation across the Metazoa and perhaps, 
provide a cautionary note for transgene expression studies within the 
parasite. 
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Staphylococcus aureus is a gram-positive bacterium that has gained 
notoriety in recent years as a major cause of serious hospital-acquired 
infections, including soft tissue infections and bacteraemia. S. aureus is 
carried asymptomatically by around one third of healthy adults, and this 
reservoir of carried strains is thought to play an important role in the 
generation of genetic diversity among S. aureus. As part of a carriage 
surveillance study in Oxford, we have collected 1991 S. aureus isolates, 
including multiple longitudinal samples from healthy participants taken at 
two-month intervals over a period of up to 24 months. We are interested in 
the genetic diversity among carried and disease isolates, with the aim of 
using this information to inform studies into transmission patterns of S. 
aureus. Samples were selected such that each individual carried only a 
single S. aureus sequence type, as determined by spa typing. For each 
sample, 12 isolates per timepoint were cultured from nasal swabs and 
sequenced on the Illumina platform. Illumina reads were mapped to the 
closest available reference genome, using the Maq mapping software. We 
applied a custom, highly specific filtering algorithm to identify high-quality 
variable sites for which there was good support in the data. Even within 
these apparently homogeneous samples, whole genome sequencing clearly 
revealed multiple distinguishable genotypes carried by a single individual at 
a given timepoint, as well as evidence of continuing evolution within each 
of those genotypes. It is evident that conventional typing techniques 
underestimate the diversity of S. aureus genotypes in carriage, and that this 
level of diversity within a single individual has to be taken into account 
when examining possible routes of transmission between epidemiologically 
linked cases. 
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Diarrhea is one of the most common causes of mortality and morbidity 
among infants and children in developing countries. In Bolivia, diarrhea is 
the second cause of mortality in children under 5 years. However, little is 
known concerning the principal pathogens involved with the disease. The 
prevalence of Diarrheagenic E. coli (DEC) and rotavirus was determined 
using routine bacteriology and molecular assay techniques in 1673 stool 
samples collected from children with diarrhea less than five years of age 
from hospitals of La Paz and Cochabamba, Bolivia during 2007 and 2008. 
The most frequently isolated enteric pathogens were rotavirus (46.6%), 
enteroaggregative E. coli (EAEC, 12.6%), enterotoxigenic E. coli (ETEC, 
7.7%) and enteropathogenic E. coli (EPEC, 6.6%). Multiple pathogens 
were recovered from 12.5 of the diarrheagenic children with the virus-
bacteria combination as the most frequent (10.3%). The seasonal 
distribution showed a high prevalence of rotavirus during the dry and cold 
season (June) and the presence of biannual distribution for ETEC with 
peaks during the transition time (May and September). Rotavirus infection 
is mainly present in children under 12 months, while infection with bacteria 
is present between 6 and 18 months for EAEC and EPEC and between 8 
and 24 months for ETEC. High frequency of resistance to ampicilin 
(75.5%), trimetoprim/sulfamethoxazole (59%) and tetracycline (44.3%) was 
displayed among Escherichia coli strains. Etiologic data on diarrheal 
disease and susceptibility patterns of diarrheal pathogens are important tools 
for clinical management and control strategies planning. 
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India is one of the very few countries where two major human malaria 
parasites, Plasmodium falciparum and P. vivax coexist. Since malaria due to 
P. vivax is comparatively rarely lethal than P. falciparum, research on P. 
vivax has attracted less attention. However, malaria morbidity caused by P. 
vivax infections contributes significantly to high socioeconomic burden in 
India. Population genetic studies can contribute significantly to understand 
evolutionary history of species populations in general, and of gene and 
genome evolution, in particular. However, very little is known about the 
genetic structure and demographic history of P. vivax in India. Thus, in 
order to gain insights into population structure and demography of P. vivax, 
we developed 11 putatively neutral DNA markers located in non-coding 
regions of a highly conserved ~200Kb region of P. vivax 13th chromosome. 
Sixty one P. vivax isolates were collected from six geographically distant 
regions of India. Altogether thirty five single nucleotide polymorphisms 
(SNPs) were identified in these 11 non-coding regions spanning about 5 Kb 
region in each P. vivax isolate. We utilized the data on the distribution of 
the SNPs to estimate genetic diversity and calculate different other 
population genetic parameters. The net genetic diversity was found to be 
variable across populations, and all the populations were found to follow 
the model of constant population size. Genetic differentiation between pairs 
of populations was not remarkable, suggesting that Indian populations of P. 
vivax are less genetically structured. Several other population parameters 
were estimated and will be discussed in detail. 
 37 
ANALYSIS OF BACTERIA FROM INTESTINAL TRACT OF FAP 
PATIENTS FOR THE PRESENCE OF APC-LIKE SEQUENCES  
 
Vladimir Holec1,2, Sonia Ciernikova3, Lenka Wachsmannova3, Zuzana 
Adamcikova3, Michal Mego4, Viola Stevurkova3, Vladimir Zajac2,3  
 
1Comenius University, Medical faculty, Pathological Anatomy, Bratislava, 
81108, Slovakia, 2University Children's Hospital, Clinic of Pediatric 
Oncology and Hematology, Banska Bystrica, 97409, Slovakia, 3Cancer 
Research Institute, Cancer Genetics, Bratislava, 83391, Slovakia, 4National 
Cancer Hospital, Internal, Bratislava, 83101, Slovakia 
 
Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary 
predisposition presented by hundreds or thousands of polyps in the intestine 
with nearly 100% penetrance. This disease is induced by germ mutations in 
the tumorsupressor APC gene, which is in the process of carcinogenesis a 
critical event. We have found that the presence of APC-like sequences in 
bacteria of FAP patients could be beneficial in analyzing the causes of the 
existence of a disproportionate number of germinal mutations in the APC 
gene. We could hypothetically consider about horizontal transfer of genetic 
information between eukaryotic and prokaryotic cells. In the event of 
confirmation of this fact, this original model could bring new opportunities 
in research, diagnosis and therapy of this disease. Our present results 
support this hypothesis, because most of the APC-like sequences in bacteria 
are located in the MCR (mutation cluster region), where the majority of 
germ mutations is located. This fact will be proven by sufficiently large 
group of patients.  
Thus, if one of the mutation sources were bacteria containing mutations in 
APC-like sequences, their limitation would be possible by means of 
probiotic bacteria. Pathological microflora could be competitively expelled 
by application of probiotics and thereby is created a basic form of treatment. 
Beneficial effect in preventing colon cancer with probiotic bacteria have 
been already demonstrated in some studies.  
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Background: The food-borne pathogen Campylobacter jejuni is a leading 
cause of bacterial gastroenteritis in humans. Multiple highly mutable loci, 
or contingency genes, have been detected in C. jejuni and are coincident in 
the genome with genes responsible for synthesis of surface exposed 
molecules. These regions consist of mononucleotide tracts that are prone to 
slipped-strand mispairing during replication that leads to an insertion or 
deletion (indel) mutation. It has been suggested that variability at these loci 
is a mechanism for adaptation to a dynamic intestinal environment and/or 
immune avoidance. We hypothesized that specific phases of contingency 
genes would be selected due to serial passage in a mouse model. 
Methods: Campylobacter jejuni NCTC 11168 was serially passaged four 
times in mice to adapt the bacteria to this host. Phenotype tests, microarray 
analysis, PFGE, and re-sequencing of the adapted C. jejuni has been 
performed. 
Results: Serial passage resulted in decreased time to develop pathology, 
and increased severity of gross pathology and histopathology. These 
measures indicate a trend toward increased C. jejuni virulence after 
adaptation to the mouse gastrointestinal tract. Interestingly, standard in vitro 
assessments of virulence would suggest the adapted bacteria was less 
virulent. To understand the genetic mechanism of this adaptation, 
microarray analysis was first performed. Overexpression of a region in the 
flagellar glycosylation locus was detected in bacteria isolated after passage. 
This region contains mononucleotide tracts, and sequence analysis revealed 
indels in these loci after passage. Illumina re-sequencing to ~250-400X 
coverage allowed us to define all contingency genes in the genome before 
and after in vivo adaptation. Single nucleotide polymorphisms and small 
indels were discovered in our lab’s C. jejuni relative to the published 
reference genome, but the only detected change in the adapted C. jejuni was 
in contingency genes. 
Conclusions: Specific phases of contingency genes appear to be selected 
during in vivo passage of C. jejuni. This finding, coupled with the apparent 
lack of other genetic changes, is the first experimental evidence that these 
loci play a significant role in C. jejuni adaptability to a novel environment. 
Because the natural reservoir of C. jejuni is in avian species, these regions 
are likely to be significant for the ability of the bacteria to colonize and 
cause inflammation in another novel host, humans. 
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Within the genus Neisseria pathogenesis has emerged from harmless 
progenitors on at least several occasions. It is yet to be fully understood as it 
is a complex polygenic trait in both gonococci and hyperinvasive 
meningococci. Comparative whole genome studies of multiple bacterial 
isolates with defined phenotypes provide a potentially powerful approach to 
studying meningococcal and gonococcal disease, but such studies present 
appreciable challenges in integrating and analysing large, complex datasets. 
 
Here we propose a scalable isolate-centric approach to whole genome 
analysis and have developed and implemented via the Internet software that 
realises this paradigm (Bacterial Isolate Genome Sequence Database, 
BIGSdb). For each isolate provenance and phenotypic properties are linked 
to the sequence data, which may range from a single gene fragment, 
through multi locus sequence data and partial genome assemblies, to a 
whole closed genome. These sequence datasets can be queried with 
standard bioinformatics algorithms using curated reference datasets for 
given genetic loci. This enables the rapid discovery and characterisation of 
genetic variation and its association with known phenotypes. These loci can 
be grouped into schemes with unlimited numbers of members to reveal 
higher order structure, as in MLST, but schemes for metabolic processes, 
antibiotic resistance, and antigenicity are also possible. BIGSdb is currently 
running the reference and isolate databases for Neisseria sequences 
(http://pubmlst.org/neisseria/) where it hosts provenance and genotypic data 
for over 17000 isolates, including 22 complete genomes. It is also currently 
being used as an in-house tool to analyse the genomes of 200 N. 
meningitidis isolates, but there are no practical limits to the number of 
bacterial genomes, loci, and schemes which can be accommodated. The 
platform is available as a resource for community annotation and 
investigation of phenotypic and genotypic variation. 
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Enterotoxigenic Escherichia coli (ETEC) is one of the most common causes 
of acute watery diarrhoea in low-income countries, causing approximately 
400 000 deaths in children under the age of five every year. ETEC produce 
two main plasmid-encoded virulence factors; colonization factors (CFs), 
which adhere to the small intestine, and a heat-stable (ST) and/or a heat-
labile (LT) enterotoxin. More than 20 CFs have been identified so far. One 
of the most common CFs woldwide is coli surface antigen 6 (CS6). The aim 
of this study was to determine the genetic relationship between CS6 positive 
ETEC strains isolated worldwide. The chromosomal genetic relationship 
was determined by Multi Locus Sequence Typing (MLST) by a scheme 
based on sequencing of internal regions of E. coli housekeeping genes adk, 
fumC, gyrB, icd, mdh, purA and recA. The ST type (STh or STp) was 
determined by multiplex PCR. The CS6-encoding operon was analyzed by 
sequencing of a 540 bp region previously shown by us to exhibit variability 
in LT-only strains. As previously reported by us, the MLST sequence type 
398 was the most common among STp/CS6 isolates from children in a 
Guatemalan village. Sequence type 398 also infected adult travellers in 
Guatemala and persisted in the region for at least six years (1998-2003). 
The same sequence type has now also been found in an ST/CS6 isolate from 
Qatar. The second most common sequence type identified in Guatemala and 
Mexico, sequence type 182, has now been identified in Turkey and Egypt. 
In Guatemala and Mexico, all 23 strains positive for STp were identical in 
the sequenced part of the CS6 operon. The same CS6 sequence has now 
been found in 9 STp/CS6 isolates from Bangladeshi children aged 0-2 
years. The CS6 sequence of an STh/CS6 isolate from a child in Guatemala 
differed greatly from the sequence in the STp/CS6 strains, and has now also 
been identified in an STh/CS6 isolate from a Bangladeshi child. The study 
is ongoing and is being expanded to include a larger number of clinical 
isolates from around the world. 
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A highly invasive form of non-typhoidal Salmonella (NTS) disease in 
humans, mostly associated with Salmonella enterica serovar Typhimurium 
isolates, has emerged in many parts of sub-Saharan Africa. Host factors 
associated with the diseases in clinical settings include HIV, young age, 
immunesuppression, malaria and anaemia. The invasive S. Typhimurium 
isolates are mainly of multilocus sequence types (ST) 313 and 19 and some 
harbour multi-drug resistance cassettes.  
 
Relatively little is known about the biology or phylogeny of S. 
Typhimurium isolates and the evolutionary relationship between these and 
non-invasive gastroenteritis-associated S. Typhimurium from other parts of 
the world. Preliminary analyses of the genome sequence of three invasive 
isolate genome sequences have shown little sequence diversity. In our 
studies, the population structure of invasive S. Typhimurium isolates from 
sub-Saharan Africa has been analysed by determining whole-genome-SNP 
based phylogeny of invasive strains against the background of global 
gastroenteritis strains from other parts of the world. Three clusters have 
been identified within which there is strong evidence of on-going 
microevolution. Subsequent investigations will explore the underlying 
genetic variation that underpins evolutionary changes over time and 
geographical space.  
 
The metabolic variation and differences in in vivo colonisation patterns 
between invasive and gastroenteritis S. Typhimurium isolates were 
examined using phenotypic microarray studies and the murine infection 
model, respectively. The invasive isolates formed distinct clusters based on 
metabolic profiles similar to the phylogenetic clustering, inferring a 
correlation between observable phenotypic characteristics to genetic 
variation. Results obtained from systemic and intestinal colonisation studies 
in mice reveal heterogeneity in the invasive potentials of different invasive 
S. Typhimurium.  
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Escherichia coli exists as the major facultative anaerobe in the human 
gastrointestinal tract, but also can cause serious disease especially in young 
children, travelers and those that do not have access to clean water. While 
E. coli/Shigella have been a model microbial system in use for decades the 
advent of the genomic era has allowed unprecedented insight into the 
variation of this important species. There are currently six readily 
identifiable and generally agreed upon pathogenic variants of diarrheagenic 
E. coli/Shigella. We have determined that there are ~2200 genes that all E. 
coli/Shigella share and each novel genome will provide approximately 300 
new genes. These two factors together indicate that the pan-genome of E. 
coli/Shigella is open and ever expanding. We identified that there is 
relatively little conservation among many of the pathovars suggesting that 
there are multiple routes of evolution for each of these groups. We have 
focused initial efforts on sequencing multiple strains of Shigella from 
multiple geographic locations and representatives of each of the species. 
Gene independent genome analysis has identified core genomic content that 
highlights the diversity of this group of pathogens and provides a finer 
resolution view of chromosomal evolution of these pathogens. Gene based 
comparisons has identified genomic regions that are species-specific as well 
as clinical presentation-specific. Comparative genomics has reached a new 
era where the number of strains that can be rapidly sequenced will begin to 
address epidemiological questions and become a more integrated 
component of the global health care system. 
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Bat is the second most diverse mammals on the earth. Increasing data 
indicate that bats harbor diverse viruses and some of them cause severe 
human diseases. In this study, random-polymerase chain reaction (rPCR) 
and high throughput sequencing technology (Solexa) was applied for 
metagenomic analysis of viruses harbored in bat intestinal tract. Bat feces 
were collected from six different locations and used for virus concentration 
and purification. The nucleic acid of purified viruses was extracted and used 
for Solexa sequencing. A total of 8,746,417 reads with a length of 
306,124,595bp, were obtained. Among them, 13541 reads have homologies 
to phages, 9170 reads to other viruses. A total of 105 assembled contigs 
(>75nt) have been constructed and compared with GenBank, 22 contigs 
showed identities of 68-99% to known virus genomic sequences, 83 showed 
identities of 20-95% to viral protein sequences. The most frequent reads and 
contigs are homologous to densoviruses, dicistroviruses, coronaviruses, 
paroviruses and tobamoviruses, covering invertebrate viruses, vertebrate 
viruses and plant viruses. This study provides a more comprehensive 
understanding of virome in bat intestinal tract which may guide the 
discovery. 
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In a search for the wildlife reservoir of SARS coronavirus (SARS-CoV), we 
used an ELISA to screen individuals from two orders of wild and domestic 
mammals in Hubei Province, China, where bats have recently been found 
infected with bat SARS-like CoV, for SARS-like CoVs. We also screened 
samples by RT-PCR. We found serological evidence of exposure to SARS-
like CoVs in 4/24 (16.67%) of Chinese ferret badgers (Melogale moschata); 
1/7 (14.29%) of hog badgers (Actonyx collaris); 6/18 (33.33%) of Edward’s 
rat (Leopoldamys edwardsi); and 2/37 (5.41%) of palm civets (Parguma 
larvata). We found no evidence of exposure in small numbers of wildcaught 
Eurasian badgers (Meles meles) or domestic dogs, pigs or cats. We also 
found no viral sequences in any of the samples by RT-PCR. This is the first 
demonstration of exposure to SARS-like CoVs in wild mammals other than 
bats outside wildlife markets in China, and it suggests that a large diversity 
of SARS-like CoVs exists in wild mammals in China, and/or that the 
viruses carried by bats also circulate within a range of wild mammal 
species.  
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We analyzed a collection of 284 diverse E. coli isolates to determine if there 
were molecular signatures associated with specific host types. This would 
lead to development of diagnostic tests to assess virulence potential and 
need for remediation when water sources are contaminated with E. coli. 
Phylogenetic analysis was performed using the sequences of three 
intergenic, promoter-containing regions of the E. coli genome, controlling 
production of curli fimbriae (csgD/B), flagella assembly and motility 
(flhDC), and nutrient import (ompF). These regions were chosen because 
the associated gene products are conserved, known to exhibit variation, and 
expressed on the cell surface. Isolates were also analyzed for the presence 
of key virulence genes and phenotypic and metabolic (BIOLOG) testing 
was performed. The E. coli isolates were clearly differentiated into four 
commonly known phylogenetic groups (A, B1, B2 and D), with virulence 
genes most prevalent in group B2 and D isolates, as expected. In general, 
isolates from the same host type did not cluster together, except that 50% of 
human isolates were in the B2 subgroup and 56% of non-human isolates 
were in the B1 subgroup. All B1 isolates were highly similar, whereas 
isolates in groups B2 and A displayed comparably greater genetic distances. 
This indicated that B1 isolates had few molecular adaptations to a particular 
host environment and were predicted to be “host-generalist”, whereas group 
A and B2 isolates were much more likely to be “host-adapted”. In 
agreement with this hypothesis, prevalence of the rdar morphotype, a 
phenotype associated with survivability in the environment and long-term 
persistence, was significantly higher in B1 isolates (84%) than either B2 
(41%) or A isolates (34%). There were no clear trends for phylogenetic 
groups or host types with respect to metabolic capacity. Our overall 
conclusions were that isolates from humans are more likely to contain 
virulence genes and appear to be more host-adapted, while E. coli isolates 
from non-human sources are generally less virulent and more host-
generalist. Given the high rates of recombination observed in many E. coli 
genomes, we hypothesize that host specificity is not reflected in genome-
wide adaptations but rather is characterized by the presence or absence of 
specific genes. 
 46 
CLUES TO TRANSMISSION: FROM SOURCE ATTRIBUTION TO 
REAL-TIME TRACKING USING PATHOGEN GENOMES 
 
Daniel J Wilson  
 
University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, 
OX4 1BN, United Kingdom 
 
The field of Evolutionary Genetics has established itself as an indispensable 
tool for solving practical problems in Infectious Diseases, providing a 
framework for understanding the genetic diversity found in pathogen 
populations. Patterns of genetic variation are informative about 
transmission, allowing us to reconstruct the epidemiological dynamics of 
pathogen populations, identify dominant transmission routes, and even to 
infer direct transmission events between epidemiologically related 
individuals. As the genetic resolution at which we can feasibly type 
pathogens has steadily increased, the Evolutionary Genetics revolution has 
become increasingly ambitious in its goals. 
 
The aim of the Modernising Medical Microbiology consortium – a 
collaboration between the University of Oxford, the Wellcome Trust Sanger 
Institute, the UK Health Protection Agency and the NHS – is to rapidly 
detect and track the spread of clinically relevant pathogens in near-to-real 
time in order to facilitate measures for control and prevention. Using a 
combination of high-throughput whole genome sequencing and novel 
evolutionary analyses, we can characterise the evolution and epidemiology 
of clinical and carriage isolates in order to understand transmission with a 
view to design control and prevention strategies. 
 
Drawing on examples from species such as Campylobacter jejuni, 
Staphylococcus aureus, Clostridium difficile and norovirus, I will illustrate 
how the tools of Evolutionary Genetics illuminate our understanding of 
transmission, from attributing the population-of-origin of zoonotic 
pathogens, through quantifying the intrinsic rate of spread of outbreak 
strains, to reconstructing direct transmission pathways at the individual host 
level. 
 
I will discuss the issues of reliably identifying variants and coping with the 
complexities of recombination, population structure and genome plasticity 
in order to fully exploit whole-genome sequences for clues they hold to 
disease transmission. 
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Bacterial DNA isolated from the intestinal tract of American and Slovak 
HIV/AIDS patients and bacteria and yeasts isolated from respiratory tract of 
Cambodian and Kenyan HIV positive children were positive in 
hybridization assay for HIV-1 specific sequences. PCR products using 
specific primers for gag, pol and env HIV-1 genes, with template of these 
DNA, were found to be for more than 90% homologous to the 
corresponding HIV-1 sequences. In Western blotting analysis were detected 
specific HIV-1 proteins using monoclonal antibodies against HIV-1 
antigens p17, p24 and gp41. Molecular weight of detected proteins are 
mostly not in accordance with corresponding viral proteins. The greatest 
consent was found in WB using MAbs against gp 41 and p17 in bacterial 
samples of all aforementioned patients. Differences between profile of 
detected protein by using MAbs against HIV-1 p24 of American and Slovak 
on the one side and Kambodian and Kenyan patients on the other one, are 
expressive. These differences are very probably determined by bacterial 
family or are results of evolutionary process. Finally, the origin of bacterial 
HIV-like sequences and the role of their products in AIDS process is 
discussed.  
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Anaplasma sp. are organisms from the Order Rickettsiales transmitted by 
ticks. Anaplasma marginale is a major impediment to livestock production 
world-wide and Anaplasma phagocytophilum, known for many years to 
cause persistent disease in ruminants, has recently been recognized as 
causing an emerging disease of humans and dogs in the U.S. and Europe. 
The causative agents have small circular genomes, ~1.2 Mb for A. 
marginale and ~1.5 Mb for A. phagocytophilum. A prominent feature of 
these genomes is the presence of numerous "functional pseudogenes" and a 
genomic locus into which duplicated pseudogenes, or pseudogene 
segments, may recombine, be expressed and generate antigenically variant 
outer membrane proteins. These pseudogenes generally consist of a central 
hypervariable region and different 5' and 3' lengths of conserved sequence 
repeated many times in different genome locations. There are ~15 
pseudogenes in A. marginale which generate variant MSP2 and MSP3 
proteins and ~100 pseudogenes in A. phagocytophilum generating variant 
MSP2/P44 proteins. The structure of these pseudogenes in each strain 
determines the repertoire of variant molecules that can be expressed. In 
turn, these repertoire differences have been linked to the ability of a 
particular strain to overcome pre-existing immunity, superinfect an animal 
already persistently infected with a different strain, and cause disease 
spread. The repertoires may also be associated with invasion of new host 
species. Expressed outer membrane protein variants are similar in U.S. 
human and dog strains of A. phagocytophilum but markedly different from 
strains infecting European ruminants. Consequently, it is important to 
determine the structure of pseudogene repertoires in different strains and 
their propensity for evolutionary change. We have obtained 454 sequence 
(regular and 3kb paired-end) for strains of Anaplasma from different 
regions of the U.S. and evaluated different de novo and reference mapper 
assembly methods for their ability to resolve the numerous repeats and 
generate reliable information about the pseudogene repertoires. The data 
suggest that these repertoires may be extremely diverse even within the 
same geographic location, but that particular pseudogenes are conserved 
across numerous strains. High-throughput sequencing should allow us to 
better understand the molecular epidemiology of larger-genome infectious 
agents, as has been achieved with viruses. 
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Legionella pneumophila and Legionella longbeachae are the etiological 
agents of Legionnaire’s disease. They are Gram-negative bacteria present in 
fresh and artificial water environments but also in soil that replicate in 
protozoan hosts and is also found in biofilms. When aerosolized bacteria are 
inhaled, they are able colonize the respiratory tract, invade alveolar 
macrophages and replicate therein causing the disease. Replication within 
protozoa is essential for the survival of these bacteria. Analysis of the 
genome sequences of L. pneumophila and of L. longbeachae revealed the 
presence of an unexpected high number and variety of eukaryotic-like 
proteins, predicted to be involved in the exploitation of the host cellular 
cycle by mimicking specific eukaryotic functions. Among those are proteins 
containing F-Box domains, U-Box domains, Sel-1 domains, Ankyrin repeat 
proteins or a sphingosin-1-phospahte lyase. Eukaryotic-like proteins have 
also been identified in other bacterial pathogens, however a comparative 
analysis shows that L. pneumophila ranks as one of the pathogens that 
encodes the most and the widest variety of eukaryotic-like proteins or 
proteins with eukaryotic domains. Recent published results and ongoing 
work show that these different proteins are implicated in modulating host 
cell functions during the intracellular life of L. pneumophila. Phylogenetic 
analyses demonstrated that both lateral gene transfer from eukaryotic hosts 
and bacterial genes that became eukaryotic-like by convergent evolution, 
contributed to the evolution of these proteins within the species L. 
pneumophila and L. longbeachae. 
 50 
HYPERVIRULENT CHLAMYDIA TRACHOMATIS CLINICAL STRAIN 
IS A RECOMBINANT BETWEEN LYMPHOGRANULOMA 
VENEREUM (L2) AND D LINEAGES  
 
Naraporn Somboonna1, Raymond Wan1, David M Ojcius2, Matthew 
Pettengill2, Sandeep Joseph3, Alexander Chang3, Ray Hsu1, Timothy D 
Read3, Deborah Dean1,4  
 
1CHORI, Immunobiology and Vaccine Design, Oakland, CA, 94609, 2Univ. 
of Calif. at Merced, Natural Sciences, Merced, CA, 95344, 3Emory Univ., 
Infectious Diseases, Atlanta, GA, 30322, 4Univ. of Calif. at Berkeley, 
Bioengineering, Berkeley, CA, 94720 
 
Chlamydia trachomatis is an obligate intracellular bacterium that causes a 
diversity of severe and debilitating diseases in humans. It is the leading 
cause of preventable blindness in tropical developing countries and the 
leading cause of bacterial sexually transmitted diseases worldwide. 
Lymphogranuloma venereum (LGV) is caused by the LGV strains of C. 
trachomatis and represents a neglected tropical disease. Recently, sporadic 
and ongoing outbreaks of LGV among men who have sex with men have 
been documented in Europe and the US. These findings support the need for 
research on virulence factors associated with these organisms. Previous 
analyses of LGV included genome sequencing of the laboratory-adapted 
reference strain L2/434 and the outbreak strain L2b/UCH-1. We isolated an 
LGV strain, termed L2c, from a man with severe proctitis but no inguinal 
adenopathy. Morphologically, L2c developed non-fusing, grape-like 
inclusions in culture unlike other LGV strains described to date. Genome 
sequencing revealed L2c to consist of a community of recombinants with 
similar regions of genetic exchange. The consensus sequence contained a 74 
kb region from C. trachomatis strain D and a partial, yet functional, 
cytotoxin gene. Indels (insertion/deletions) occurred in a promoter region 
for the ftsK gene, and in the tarp and hctB genes that encode key proteins 
involved in replication, intracellular inclusion formation, and histone H1-
like protein activity, respectively. Analyses suggest that the indels affect 
protein function, supporting the clinical and in vitro findings for L2c. L2c 
represents the first genomic evidence for recombination between C. 
trachomatis strains. The finding of a heterogeneous community of 
recombinants suggests that L2 and D either produced a number of 
recombinants in the rectal mucosa of the patient or that there were a number 
of clonal populations of L2c recombinants circulating among the patient’s 
core sexual group. The recombinants resemble the “quasi-species” of 
genetically diverse individuals frequently reported in viral populations. 
Given the lack of a genetic system for producing stable mutants of C. 
trachomatis, identifying naturally occurring clinical recombinants such as 
L2c can clarify the functions of specific genes and provide opportunities for 
discovering avenues for genomic manipulation. 
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Leptospirosis is a globally important zoonotic disease caused by diverse 
spirochetes in the genus Leptospira which is divided into pathogens, 
intermediates, and saprophytes. Genomic analyses of pathogens (L. 
interrogans, L. borgpetersenii) and a saprophyte (L. biflexa), have produced 
insights into genomic organization/reduction and genes selectively found in 
pathogens vs. saprophyte, but have not predicted pathogenicity 
mechanisms. To identify genes potentially associated with virulence, we 
employed two strategies: (1) comparative whole genome analysis of an 
intermediate Leptospira, the newly discovered L. licerasiae, from the 
Peruvian Amazon; and 2) identification of mutations in L. interrogans 
associated with in vitro attenuation by whole genome sequencing. 454 
sequencing of L. licerasiae demonstrated a genome size (~4.2 Mbp) 
intermediate between that of pathogens (~4.8 Mbp) and saprophytes (~3.9 
Mbp). L. interrogans and L. licerasiae share 2545 genes, of which 158 were 
not found in either the saprophyte, L. biflexa, or the strictly parasitic L. 
borgpetersenii. Pathogenic and intermediate Leptospira share more 
orthologs with each other than with saprophytes (378, 225 with predicted 
function, others being conserved hypothetical proteins), suggesting genes 
associated with virulence and/or mammalian host-pathogen interactions. 
Such genes include those implicated in environmental sensing and signal 
transduction, and cobalamin (cob operon, Vitamin B12) metabolism. 
Selective retention of the cob operon by infectious Leptospira suggests a 
role in virulence/pathogenicity, yet all sequenced leptospiral genomes 
encode two enzymes that require B12 for function: methylmelanoyl-CoA 
mutase and B12-dependent methionine synthetase, MetH. These results 
suggest that enhanced in vivo synthesis of vitamin B12 may contribute to 
survival within the host. To identify potential virulence genes, a highly 
pathogenic strain of L. interrogans Lai [Passage 1 (P1) LD50 < 100] was 
attenuated by serial passage. Comparison of P1 vs P19 Solexa-sequenced 
genomes demonstrated 15 non-synonymous SNPs, likely to represent 
pathogenicity-associated genes. These included 2 adenylate cyclases unique 
to pathogenic Leptospira with amino acid changes in essential functional 
domains. Despite recent microarray, transposon mutagenesis, and targeted 
gene deletion studies, translation of genomic information to the inference of 
specific leptospiral virulence mechanisms remains in its infancy. Genomic 
approaches to identify potential virulence-associated genes in Leptospira 
may yield new insights into pathogenetic mechanisms of leptospirosis. 
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Persistent bacteria survive drug treatment despite lacking alleles that code 
for genotypic drug resistance. The phenomenon of persistence may be the 
basis of the need for lengthy treatment regimens to cure tuberculosis and 
could also contribute to the ability of the bacteria to establish a latent 
infection. 
A basic experimental model of persistence involves treating M. tuberculosis 
cells with isoniazid, an antibiotic that provokes a lytic death of the cell. 
After four days of treatment, 99.9% of the population has been killed and 
the remaining cells are persisters; genotypically drug sensitive survivors of 
drug treatment. The transcriptional profile of these persister cells was 
compared to untreated cells. The most differentially expressed gene not 
affected by short-term isoniazid treatment was a putative transcription 
factor, whiB6. We created whiB6 knock out and complemented strains and 
compared the transcriptional profile of the whiB6 mutant and complemented 
strains with the wild type strain. Many of the differences in gene expression 
seen in the persister cells were absent in the whiB6 mutant and these 
differences were restored with the complemented strain. We have 
investigated the behavior of the whiB6 mutant in a mouse model of drug 
treatment, latency, and reactivation. The mutant was more effectively killed 
by drug treatment in the context of the mouse and may be less likely to 
enter a latent state. 
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Introduction  
Capsular polysaccharide plays an important role in virulence and is the basis for 
immunological serogrouping. Thirteen serogroups have been described: A, B, 
C, D, 29E, H, I, K, L, W-135, X, Y and Z. This study explored the genetic 
relatedness of the capsule operon among all thirteen serogroups. It made use of 
the Bacterial Isolate Genome Sequence Database (BIGSdb) which is a scalable, 
open source, web-accessible database system. 
Methods  
The operon was sequenced in a representative N. meningitidis isolate from each 
serogroup. Serogroup A, B and C capsule operons were obtained from the 
genomes belonging to isolates FAM18 (C), 053442 (C), MC58 (B) and Z2491 
(A). Sequences were deposited in the BIGSdb from which schemes for each 
capsule region were devised. 
Results  
Genes necessary for capsule expression are clustered within the capsule gene 
complex that comprises 5 regions (A–E). Genes in regions A, B and C are 
responsible for capsule synthesis, modification and transport while region D 
contains genes for LPS synthesis. Region E contains the tex gene. All of the 
serogroups examined had similar organisation of the capsule with regions 
occurring in the order D-A-C-E-D’-B. Serogroup H contained 4 genes in region 
A, two of which identical to capZa and capZb involved in serogroup Z capsule 
synthesis. Serogroups I and K had identical capsule operons with 5 genes in 
region A designated capIKa-capIKe. Three of these genes shared sequence 
identity with genes involved in capsule synthesis in Pasteurella suggesting 
horizontal genetic exchange. Serogroup D was found to be a serogroup C 
isolate.  
Conclusion  
Isolates with serogroup H, I, K and L capsules have been rarely reported since 
their description in the 1980s such that only 2 serogroup K and 8 serogroup H 
isolates have been deposited in the PubMLST database with no further 
descriptions of serogroups I and L. Sequencing of the capsule operon revealed 
that D was identical to C suggesting that this serogroup does not exist. It is 
proposed that N. meningitidis be classified into 12 serogroups A, B, C, 29E, H, 
I, K, L, W-135, X, Y and Z. All of the sequenced capsule operons have been 
deposited in BIGSdb and are being used as a reference set to probe for the 
capsule operon among N. meningitidis genomic DNA deposited in the database.  
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Streptococcus agalactiae is a leading cause of neonatal infections in 
humans. It is a commensal frequently isolated from the digestive and 
genitourinary tracts that could be transmitted from the mother to the 
newborn at birth. However, S. agalactiae was initially described as 
responsible for bovine mastitis and more recently for epidemic events of 
invasive diseases in fish farms. More specifically, a lineage was identified 
with specific phenotypic properties. One strain from this lineage, 
responsible for epidemic events in fish farms in Israel was initially 
described as a new streptococcus species named S. difficile. 
The complete genome sequences of 8 strains of human origin are currently 
available. We have now sequenced the genomes of five strains responsible 
for infections in cold blood animals (fish and frogs) including the original S. 
difficile strain (2-22) 
The three strains isolated from cold blood animals share a thermosensitive 
growth, a hydrophobic surface and the loss of the capacity to metabolize 
different sugars. They are genetically closely related with an overall 
polymorphism lower than 1 SNP per kb. The most remarkable feature of 
their genome is the massive reduction in genome size by more than 20% 
resulting from a large number of deletions and the loss of almost all 
genomic islands. Furthermore, more than 12% of the remaining genes are 
putative pseudogenes as a result of internal deletions, frame shift mutations 
and in frame stop codons. In agreement with the phenotypic properties, this 
gene loss affects mostly genes encoding metabolic functions, surface 
proteins, regulatory functions and almost all known virulence factors, the 
polysaccharide capsule remaining the only conserved one. 
As described for human pathogens, like Salmonella typhi or Bordetella 
pertussis, the shift from a commensal to a professional pathogen is 
associated with genome reduction. The access to multiple strains from this 
lineage isolated in different parts of the world with different sets of 
deletions and pseudogenes allows to investigate its history and the 
molecular mechanisms underlying the genome reduction and provide a 
model to study increased virulence and host restriction associated to high 
population density of the host. 
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Schistosomiasis, the most important of the human helminth infections, is 
often described as a “neglected” disease. The publication of the 
Schistosoma mansoni genome sequence provides opportunities to 
reinvigorate research on this parasite. We have exploited the genome 
sequence to develop forward genetic methods (i.e. linkage mapping) to 
identify the genes that underlie phenotypic variation in this parasite. This 
approach is well suited to S. mansoni as the lifecycle can be maintained in 
the laboratory and clonal propagation of parasites within snails generates 
large numbers of genetically identical parasites. Furthermore schistosomes 
show heritable variation in many biomedically important traits such as drug 
resistance, host specificity, and virulence. To generate a genetic map and 
help assemble the fragmented genome sequence, we staged a genetic cross 
and genotyped parental, F1 and F2 parasites using microsatellite markers 
placed in the largest sequence scaffolds. In this way we generated a 5 cM 
genetic map and were able to assign and order ~70% of the scaffolds onto 
chromosomes. To provide proof-of-principal that linkage mapping is 
feasible and powerful we used the genetic map and a second cross to 
identify the genome region that underlies resistance to oxamniquine (OXA). 
Resistance to this drug has arisen in nature, has a simple recessive basis and 
results in ~500-fold reduction in drug sensitivity. We measured OXA-
resistance by monitoring death of cultured worms following drug exposure 
and genotyped parents, F1 and F2 progeny using markers distributed across 
the genome. As expected trait segregation in the cross was consistent with 
recessive inheritance as F1s were sensitive and ~25% of F2 progeny were 
resistant. We found a strong QTL (LOD = 5.4) on chromosome 6 where 
microsatellite markers segregate closely with OXA resistance. The two 
parents of this cross have now been sequenced, simplifying fine mapping 
and identification of candidate genes. Successful identification of gene(s) 
that underlie OXA-resistance will provide insights into mode of drug action, 
allow development of modified compounds that kill resistant parasites, 
generate selectable markers for genetic manipulation, and set the stage for 
forward genetic analyses of a range of biomedically important traits 
including praziquantel resistance.  
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Chagas disease, endemic to the Americas, is caused by life-long infection 
with the parasitic protozoan Trypanosoma cruzi. Genetically diverse, T. 
cruzi is classified into the intra-species lineages TcI-TcVI, with disparate 
ecologies and geographical distributions. Disease outcome may be linked to 
parasite lineage, complicated by mixed infections and divergent tissue 
tropism. Lineage-specific serology would be an important new tool in 
understanding Chagas disease epidemiology.  
The T. cruzi trypomastigote small surface antigen (TSSA) has previously 
been described to serologically identify infection by TcII-VI, as distinct 
from TcI, on the basis of a biallelic TSSA resulting in two isoforms of the 
mature protein containing distinct epitopes. However, we have recently 
shown by analysis of TSSA nucleotide and predicted amino acid sequences 
across a panel of reference biological clones representing all lineages, that 
TSSA epitope polymorphism is greater than previously described. The 
epitope considered to be serologically characteristic of TcII-VI is restricted 
to TcII, V, and VI, while epitope forms found in TcIII and TcIV share key 
features with TcI. Furthermore, TSSA sequences inferred greater 
phylogenetic affinities of TcIII and TcIV to TcI than to TcII, V, or VI, and a 
high ratio of non-synonymous/synonymous nucleotide substitutions 
(ω=1.233) suggests that TSSA has been under positive selection pressure by 
the vertebrate host.  
By using synthetic peptides based on these lineage-specific TSSA epitopes, 
we are currently developing an ELISA for serological studies of an 
individual’s history of infection by different T. cruzi lineages. Early results 
using this method have identified evidence of TcII infection in patient sera 
from Brazil. Additionally, an in silico ‘comparative genomics’ approach to 
the recently sequenced genomes of T. cruzi lineage reference strains 
demonstrates a new means to identify novel lineage-specific antigens, 
which has broad applicability to neglected infectious diseases.  
 
Supported by EC ChagasEpiNet.  
 57 
MAINTENANCE AND EVOLUTION OF PLASMODIUM 
FALCIPARUM GENETIC DIVERSITY SUSTAINING A LOW 
TRANSMISSION MALARIA ENDEMIC IN THE PERUVIAN AMAZON 
 
OraLee H Branch1, Patrick L Sutton1, Juan Carlos Castro-Gomez2, Carmen 
R Barnes3, Gisely Hijar-Guerra3  
 
1New York University, Medical Parasitology, New York, NY, 10016, 
2Universidad Nacional Amazonia Peruana, Laboratorio Investigaciones 
Productos Naturales Antiparasitarios de la Amazonia, Iquitos, 065, Peru, 
3Instituto Nacional de Salud, Laboratorio de Biotecnologia y Biologia 
Molecular, Lima, 001, Peru 
 
P. falciparum entered into the Peruvian Amazon in 1994, sparking an 
epidemic between 1995 and 1998. Since 2000, there has been sustained, 
low P. falciparum transmission. The Malaria Immunology and Genetics in 
the Amazon project has longitudinally followed members of the community 
of Zungarococha (N=1945, 4 villages) with active household and health 
center-based visits each year since 2003. We examined parasite population 
structure and traced the parasite genetic diversity throughout time and 
space. We typed infections occurring from 2003-2007 using 14 
microsatellite (MS) markers scattered across 9 different chromosomes. 
Despite low transmission, there was considerable genetic diversity which 
we compared to other geographic regions. This study included 182 different 
haplotypes from 302 parasites in 217 discrete infections. Population 
structure was characterized by two different methods. The first method 
broadly grouped haplotypes into clusters of phylogenetically related clones, 
while the second method grouped haplotypes pairwise into haplotype 
families (hapfams) by considering haplotypes with three or less loci 
differences as members of the same family. In this population, five different 
clusters of related clones and 34 different hapfams were identified. Hapfams 
with the greatest amount of within-family diversity (polymorphic hapfams) 
were consistently redetected over time, relative to the monomorphic 
hapfams. Controlling for haplotype frequency and possible mutation, the 
monomorphic hapfams were shown to go extinct. Over time the diversity 
was maintained, within a village the hapfams persisted, but with one or two 
differences (polymorphisms). The population structure, genetic diversity, 
appearance/disappearance of the different haplotypes over time has 
provided a genome-wide, ‘real-time’ perspective into how P. falciparum 
parasites are maintained in endemic transmission. We relate this to the high 
level of asymptomatic malaria infections in this population, speculating that 
the MS markers might be linked to antigen genes and that the immunity in 
this population is selecting for variation across the genome. 
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SchistoDB (www.SchistoDB.net) is a genomic database for Schistosoma 
mansoni. The database uses the Genomics Unified Schema, GUS, and currently 
contains S. mansoni sequence data (Genomic, EST) and ~13 thousand 
automated gene predictions. SchistoDB offers a variety of tools including 
BLAST, protein motif searches, keyword searches of pre-computed BLAST 
results, GO assignments and protein family information that can be queried with 
Boolean logic. Data from a number of microarray, SAGE and ChipSeq were 
also uploaded. Integrated into SchistoDB are SchistoCyc and KEGG DRUG. 
SchistoCyc is a prediction of the metabolic pathways of the organism based on 
the genomic information. Genomic data were used to computationally predict 
112 metabolic pathways. Reactions that might play a crucial role in parasite 
metabolism were identified. In order to enhance the annotation of genes we 
have reconstructed the evolutionary histories of all proteins encoded in the S. 
mansoni genome (phylome). The phylome was performed using an automatic 
pipeline as implemented in PhylomeDB. We analyzed 8.818 phylogenetic trees 
of 13.285 predicted proteins and homologs in 16 other organisms. We could 
transfer functional annotations from GO to 5.587 S. mansoni proteins (956 had 
no annotation). This approach provided us with a genome-wide view of S. 
mansoni, indicating gain, loss and gene duplication in this parasite. We have 
used the database to characterize two groups of proteins, Eukaryotic protein 
kinases (ePKs) and histone modifying enzymes (HMEs), as possible drug 
targets. ePKs play a central role in mediating signal transduction through 
complex networks. The analysis of the S. mansoni genomic data revealed 252 
putative ePKs, which corresponds to 1.9% of the parasite predicted proteome. 
For this purpose, amino acid sequences corresponding to the conserved catalytic 
domain of ePKs were aligned by MAFFT and an HMM model generated to 
scan the parasite predicted proteome. Phylogenetic analysis based on a distance 
method was implemented in PHYLIP. Our results showed the functional 
classification of the S. mansoni ePKs into nine kinase groups (AGC, CaMK, 
CK1, CMGC, STE, RGC, TK, TKL, and Others). A similar approach was used 
for the identification of 67 HMEs (14 histone deacetylases, 12 histone 
acetyltransferases, 23 lysine methyltransferases, 7 arginine methyltransferases 
and 11 histone demethylases). Selected genes are now being confirmed by 
sequencing and coded proteins used for the identification of inhibitors by 
computational and experimental approaches. 
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Malaria is one of the highly endemic infectious diseases in India with 
severe public health hazards, as it alone infects over 1.5 million Indians 
every year. Unlike other endemic countries, malaria in India presents much 
complex epidemiological patterns. These complexities chiefly been 
implicated to eco-climatic conditions that favors vector survival and 
growth, almost equal distribution of the two most-widespread species of 
human malaria parasites (Plasmodium falciparum and P. vivax), high 
proportion of mixed parasite species infections and malaria susceptible 
humans, among several others. Majority of the basic biological and 
epidemiological understandings related to malaria infection are still in 
dearth in India, which debars to formulate effective malaria intervention 
strategies. In this concern, recent advancements in genomic technologies 
offer excellent opportunities to unravel genetic mysteries of malaria 
infections. We have recently initiated evolutionary genomic research in 
Indian malaria parasites, vectors and human hosts. While results on Indian 
malaria vector phylogenomics and population genomics provide initial 
insights into evolutionary understanding, population genomics of both P. 
falciparum and P. vivax reflect genome variability and population structure 
in India. Further, important insights into evolutionary genetic outlines of 
antimalarial resistance in P. falciparum have also been gained. 
Additionally, human population genomics and genetic variations in drug 
metabolizing and malaria susceptibility genes have provided primary 
understanding on complexities of malaria infections in India. Results from 
all these studies will be presented. 
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The expression of Variable Surface Glycoproteins (VSG) on the cell 
surfaces of African trypanosomes (Trypanosoma brucei, T. congolense and 
T. vivax) allows these parasites to evade host immune responses, and is a 
textbook example of antigenic variation. Our understanding of the genetic 
diversity of VSG, regulation of their expression, and placement within the 
genome comes mainly from T. brucei, where a single VSG is expressed 
from telomeric expression sites and periodically substituted through ectopic 
gene conversion. This results in high levels of mosaicism among T. brucei 
VSG that doubtless helps the parasite to stay ahead of host immunity. We 
have sequenced the genomes of T. congolense and T. vivax, two closely 
related species, to compare and contrast the molecular structure, genetic 
diversity, and genomic architecture of VSG in all three species. We identify 
a common structural signature to VSG from all species, which each species 
has modified in different ways. Most notably in T. brucei, the VSG has 
become substantially larger through the addition of W-based and C-based 
repetitive regions at 5' and 3' ends respectively. While all species have 
comparable numbers of genes, T. brucei and T. vivax VSG are more diverse 
than T. congolense VSG, and all three species display distinct phylogenetic 
structures that indicate a fundamentally different evolutionary dynamic. We 
find much greater evidence for recombination among T. brucei VSG than 
either other species, which probably accounts for the lack of phylogenetic 
structure in the T. brucei VSG phylogeny. From the small number of T. 
congolense and T. vivax telomeres assembly, we find no evidence for an 
expression site (as defined in T. brucei), and most gene components of the 
T. brucei expression site are specific to this species. Therefore, the 
canonical VSG expressed by T. brucei has been derived relative to the 
ancestral surface glycoprotein with respect to its structure, its genomic 
position and its evolutionary dynamic. T. brucei generates greater diversity 
among its surface antigens by recombination, perhaps due to a specialised 
telomeric expression site that is apparently absent in other species. 
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Toxoplasma gondii is a highly successful parasite; it is able to infect almost 
any nucleated cell from any warm blooded animal. This ubiquity means that 
the parasite must be able to recognise a large range of host cell receptors 
and evade a variety of immune mechanisms, processes that may involve cell 
surface proteins. Among the most abundant is SAG1, now known to be part 
of a large superfamily of SAG1-related sequences (SRS), which typically 
consist of one or two SRS-domains. Previous analyses suggested T. gondii 
possess a complement of 160 SRS genes, however many have been lost in 
recent releases of the genome. Interest in the SRS superfamily continues; 
while SAG1 is immunogenic and SAG1 knockouts are less virulent, the 
detailed roles of other members are still unknown. The release of improved 
genome assemblies, together with the publication of four 3D structures 
provide an excellent opportunity to better understand into the function and 
evolution of the SRS proteins. 
 
Using current models of the SRS domain, we searched the protein sets of 
three T. gondii strains. The resulting 427 domains (from 239 proteins) were 
clustered, allowing the definition of eight distinct domain families. Further 
searches were made with family-specific HMMs, producing a final set of 
~100 SRS proteins and 35-70 pseudogenes per strain. Family pairings in 
multi-domain proteins are not random, but demonstrate strong associations 
between particular families. Mapping the SRS genes onto the genome, 
showed that the majority are present in loci of up to ten genes. These loci 
are not predominantly telomeric, as observed in other apicomplexan 
families of surface proteins. Given a phylogenetic reconstruction of 30 two-
domain SRS genes, the hypothesis is that the whole locus duplication is 
followed by concerted evolution; where inter-locus recombination makes 
each locus appear monophyletic. 
 
Conservation profiles of each domain family were mapped onto the 
available 3D structures. The majority of the family defining residues are 
found on two exposed β-sheets. Additionally, in two domain proteins, the 
surface of the domain distal to the membrane is hypervariable. These 
diverse regions may underlie different functions of each family.  
 
Taken together, these results highlight key features of SRS evolution and 
how patterns of diversity may have a consequence on their structure and 
function. 
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